<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group>
<journal-title>PLoS ONE</journal-title></journal-title-group>
<issn pub-type="epub">1932-6203</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, USA</publisher-loc></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">PONE-D-14-25482</article-id>
<article-id pub-id-type="doi">10.1371/journal.pone.0113363</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biology and life sciences</subject><subj-group><subject>Genetics</subject><subj-group><subject>Genomics</subject><subj-group><subject>Genomic medicine</subject><subj-group><subject>Genetic testing</subject></subj-group></subj-group></subj-group></subj-group><subj-group><subject>Molecular biology</subject></subj-group><subj-group><subject>Population biology</subject></subj-group></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine and health sciences</subject><subj-group><subject>Cardiology</subject><subj-group><subject>Cardiovascular diseases</subject></subj-group></subj-group><subj-group><subject>Clinical genetics</subject></subj-group><subj-group><subject>Epidemiology</subject><subj-group><subject>Genetic epidemiology</subject><subject>Molecular epidemiology</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Association of Endothelial Nitric Oxide Synthase Gene Polymorphisms with Coronary Artery Disease: An Updated Meta-Analysis and Systematic Review</article-title>
<alt-title alt-title-type="running-head"><italic>NOS3</italic> Gene Polymorphisms and CAD</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple"><name name-style="western"><surname>Rai</surname><given-names>Himanshu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Parveen</surname><given-names>Farah</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib>
<contrib contrib-type="author" equal-contrib="yes" xlink:type="simple"><name name-style="western"><surname>Kumar</surname><given-names>Sudeep</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Kapoor</surname><given-names>Aditya</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib>
<contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sinha</surname><given-names>Nakul</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib>
</contrib-group>
<aff id="aff1"><label>1</label><addr-line>Department of Cardiology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India</addr-line></aff>
<aff id="aff2"><label>2</label><addr-line>Department of Medical Genetics, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India</addr-line></aff>
<aff id="aff3"><label>3</label><addr-line>Department of Cardiology, Sahara India Medical Institute, Gomti Nagar, Lucknow, Uttar Pradesh, India</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple"><name name-style="western"><surname>Ai</surname><given-names>Jinglu</given-names></name>
<role>Editor</role>
<xref ref-type="aff" rid="edit1"/></contrib>
</contrib-group>
<aff id="edit1"><addr-line>St Michael's Hospital, University of Toronto, Canada</addr-line></aff>
<author-notes>
<corresp id="cor1">* E-mail: <email xlink:type="simple">himanshurai1981@gmail.com</email> (HR); <email xlink:type="simple">sudeepkum@yahoo.com</email> (SK)</corresp>
<fn fn-type="conflict"><p>The authors have declared that no competing interests exist.</p></fn>
<fn fn-type="con"><p>Conceived and designed the experiments: HR SK. Analyzed the data: HR FP SK. Contributed reagents/materials/analysis tools: HR FP SK. Wrote the paper: HR FP SK AK NS.</p></fn>
</author-notes>
<pub-date pub-type="collection"><year>2014</year></pub-date>
<pub-date pub-type="epub"><day>19</day><month>11</month><year>2014</year></pub-date>
<volume>9</volume>
<issue>11</issue>
<elocation-id>e113363</elocation-id>
<history>
<date date-type="received"><day>20</day><month>7</month><year>2014</year></date>
<date date-type="accepted"><day>22</day><month>10</month><year>2014</year></date>
</history>
<permissions>
<copyright-year>2014</copyright-year>
<copyright-holder>Rai et al</copyright-holder><license xlink:type="simple"><license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions>
<abstract>
<p>Several association studies of endothelial nitric oxide synthase (<italic>NOS3</italic>) gene polymorphisms with respect to coronary artery disease (CAD) have been published in the past two decades. However, their association with the disease, especially among different ethnic subgroups, still remains controversial. This prompted us to conduct a systematic review and an updated structured meta-analysis, which is the largest so far (89 articles, 132 separate studies, and a sample size of 69,235), examining association of three polymorphic forms of the <italic>NOS3</italic> gene (i.e. Glu298Asp, T786-C and 27bp VNTR b/a) with CAD. In a subgroup analysis, we tested their association separately among published studies originating predominantly from European, Middle Eastern, Asian, Asian-Indian and African ancestries. The pooled analysis confirmed the association of all the three selected SNP with CAD in three different genetic models transcending all ancestries worldwide. The Glu298Asp polymorphism showed strongest association (OR range = 1.28–1.52, and P&lt;0.00001 for all comparisons), followed by T786-C (OR range = 1.34–1.42, and P&lt;0.00001 for all comparisons) and 4b/a, (OR range = 1.19–1.41, and P≤0.002 for all comparisons) in our pooled analysis. Subgroup analysis revealed that Glu298Asp (OR range = 1.54–1.87, and P&lt;0.004 for all comparisons) and 4b/a (OR range = 1.71–3.02, and P&lt;0.00001 for all comparisons) have highest degree of association amongst the Middle Easterners. On the other hand, T786-C and its minor allele seem to carry a highest risk for CAD among subjects of Asian ancestry (OR range = 1.61–1.90, and P≤0.01 for all comparisons).</p>
</abstract>
<funding-group><funding-statement>The authors have no funding or support to report.</funding-statement></funding-group><counts><page-count count="1"/></counts><custom-meta-group><custom-meta id="data-availability" xlink:type="simple"><meta-name>Data Availability</meta-name><meta-value>The authors confirm that all data underlying the findings are fully available without restriction. Data are available as Supporting Information files.</meta-value></custom-meta></custom-meta-group></article-meta>
</front>
<body><sec id="s1">
<title>Introduction</title>
<p>Endothelial-derived nitric oxide (NO) has been known to be a major contributor in vascular regulation and has been amply implicated with coronary artery disease (CAD). NO is an important relaxing factor in the human body and is involved in a variety of different important physiological functions. It is synthesized in the human body from L-arginine by at least three isoforms of NO synthase (NOS), viz. inducible NOS, constitutive neuronal NOS and constitutive endothelial NOS (eNOS). <xref ref-type="bibr" rid="pone.0113363-Moncada1">[1]</xref> NO causes vascular relaxation, it suppresses platelet and leucocyte adhesion to the vascular endothelium <xref ref-type="bibr" rid="pone.0113363-Gardemann1">[2]</xref>–<xref ref-type="bibr" rid="pone.0113363-Colombo1">[4]</xref> and reduces smooth muscle cell proliferation and migration <xref ref-type="bibr" rid="pone.0113363-Colombo2">[5]</xref>. It also scavenges superoxide radicals <xref ref-type="bibr" rid="pone.0113363-Gardemann1">[2]</xref> and limits the oxidation of atherogenic low density lipoproteins <xref ref-type="bibr" rid="pone.0113363-Hingorani1">[3]</xref> resulting in an overall vasoprotective effect. Intracellular NO has thus been considered as an inhibitor of several key processes leading to atherosclerotic plaque formation. <xref ref-type="bibr" rid="pone.0113363-Colombo1">[4]</xref> Inhibition or reduction of NO on the other hand, may accelerate this process. NO production has been known to be influenced by several polymorphisms of the <italic>NOS3</italic> gene. The <italic>NOS3</italic> gene is located on chromosome 7q35-36, consists of 26 exons with a total size of 21 kb and it encodes for intracellular NO production <xref ref-type="bibr" rid="pone.0113363-Marsden1">[6]</xref>. This gene is expressionally and functionally regulated through multiple regulatory steps, and entails several polymorphisms <xref ref-type="bibr" rid="pone.0113363-Hingorani1">[3]</xref>, some of which have functional consequences.</p>
<sec id="s1a">
<title>NOS3 polymorphisms, their role in NO production and their vascular end effects</title>
<p>Hingorani et al., <xref ref-type="bibr" rid="pone.0113363-Hingorani2">[7]</xref> first described a point mutation of guanine (G) to thymine (T) at nucleotide 1917 in exon 7 of the <italic>NOS3</italic> gene, resulting in the replacement of glutamic acid by aspartic acid at codon 298 (Glu298Asp, also known as G894-T, rs1799983). This variant has been shown to be associated with coronary spasm, <xref ref-type="bibr" rid="pone.0113363-Yoshimura1">[8]</xref> essential hypertension <xref ref-type="bibr" rid="pone.0113363-Miyamoto1">[9]</xref> and the risk of acute myocardial infarction (AMI) <xref ref-type="bibr" rid="pone.0113363-Hingorani1">[3]</xref>, <xref ref-type="bibr" rid="pone.0113363-Shimasaki1">[10]</xref>, <xref ref-type="bibr" rid="pone.0113363-Hibi1">[11]</xref>. Controversial results have been obtained over the years when this single nucleotide polymorphism (SNP) was evaluated with respect to its effect on intracellular NO production. Some studies have demonstrated lower concentrations of intracellular NO in genotypes carrying Asp alleles <xref ref-type="bibr" rid="pone.0113363-Philip1">[12]</xref>, while others have reported lack of association of this SNP with NO production <xref ref-type="bibr" rid="pone.0113363-Angeline1">[13]</xref>. Apparently, apart from possibly having lower NO concentrations in the human body, genotypes carrying Asp alleles have also been shown to have greater red blood cell (RBC) aggregability <xref ref-type="bibr" rid="pone.0113363-BorKucukatay1">[14]</xref>. This makes them more prone to suffer from acute coronary events, especially from those of thrombotic origin. Befittingly, over the years this SNP has been shown to be associated to myocardial infarction (MI) <xref ref-type="bibr" rid="pone.0113363-Shimasaki1">[10]</xref>, <xref ref-type="bibr" rid="pone.0113363-Hibi1">[11]</xref>, <xref ref-type="bibr" rid="pone.0113363-Dafni1">[15]</xref>, coronary artery spasm <xref ref-type="bibr" rid="pone.0113363-Shimasaki1">[10]</xref> and CAD. <xref ref-type="bibr" rid="pone.0113363-Gardemann1">[2]</xref>–<xref ref-type="bibr" rid="pone.0113363-Colombo1">[4]</xref>, <xref ref-type="bibr" rid="pone.0113363-Angeline1">[13]</xref>, <xref ref-type="bibr" rid="pone.0113363-Salimi1">[16]</xref>, <xref ref-type="bibr" rid="pone.0113363-Salimi2">[17]</xref> However, association of this SNP with CAD has been a matter of dispute as some studies have also reported its lack of association with the disease. <xref ref-type="bibr" rid="pone.0113363-Cai1">[18]</xref>–<xref ref-type="bibr" rid="pone.0113363-Alp1">[23]</xref> Geo-ethnic differences and the role of environmental factors in various populations could have been the prime reason behind these contradictory results.</p>
<p>Another common variant of this gene results by a cytosine replacing a thymine at nucleotide −786 (T786-C, rs2070744) at the 5′-flanking region of the <italic>NOS3</italic> gene. <xref ref-type="bibr" rid="pone.0113363-Nakayama1">[24]</xref> The resulting T786-C variant has been shown to reduce the <italic>NOS3</italic> promoter activity approximately by 50% and has been associated with an increased risk for coronary artery spasm among subjects of Japanese ethnicity. <xref ref-type="bibr" rid="pone.0113363-Nakayama1">[24]</xref> Recently, this polymorphism has also been shown to influence the plasma NO concentrations in hypertensive and type 2 diabetes mellitus patients. <xref ref-type="bibr" rid="pone.0113363-Sandrim1">[25]</xref> It has also has been implicated as a risk factor for developing hypertension. <xref ref-type="bibr" rid="pone.0113363-Sandrim1">[25]</xref> Several published reports strongly suggest that this functional variant in the <italic>NOS3</italic> promoter region (T786-C) is associated with reduction in the promoter efficiency and the level of expressed enzyme, leading to increased CAD risk. <xref ref-type="bibr" rid="pone.0113363-Miyamoto2">[26]</xref>–<xref ref-type="bibr" rid="pone.0113363-Rios1">[28]</xref> Apart from hypertension <xref ref-type="bibr" rid="pone.0113363-Sandrim1">[25]</xref>, <xref ref-type="bibr" rid="pone.0113363-Hyndman1">[29]</xref> and coronary artery spasm, <xref ref-type="bibr" rid="pone.0113363-Nakayama1">[24]</xref> T786-C has also been investigated by several researchers for its association with the presence and severity of CAD, <xref ref-type="bibr" rid="pone.0113363-Hingorani1">[3]</xref>, <xref ref-type="bibr" rid="pone.0113363-Rossi1">[30]</xref> and MI. <xref ref-type="bibr" rid="pone.0113363-Nakayama2">[31]</xref> However, some studies have also reported no association with CAD. <xref ref-type="bibr" rid="pone.0113363-Ragia1">[32]</xref></p>
<p>There are also several variable number of tandem repeats (VNTRs) with functional significance within <italic>NOS3</italic> gene. Among them polymorphic repeats close to the 5′ end of the gene, the 27-base pair (bp) repeat in intron 4 is one of the most studied. The resulting rare 4-repeat allele has been shown to be associated with CAD among subjects belonging to European ancestry. <xref ref-type="bibr" rid="pone.0113363-Wang1">[33]</xref> This 4a/b mutation of <italic>NOS3</italic> gene was found to be associated with MI, among subjects of Turkish descent. <xref ref-type="bibr" rid="pone.0113363-Cine1">[34]</xref> Significant association of the 4a/b polymorphism with CAD and MI has been amply reported in several ethnic populations even after adjustment of traditional risk factors. <xref ref-type="bibr" rid="pone.0113363-Kim1">[22]</xref>, <xref ref-type="bibr" rid="pone.0113363-Wang1">[33]</xref>, <xref ref-type="bibr" rid="pone.0113363-Ichihara1">[35]</xref>, <xref ref-type="bibr" rid="pone.0113363-Park1">[36]</xref> On the other hand, a few groups have also reported lack of association of this SNP with CAD. <xref ref-type="bibr" rid="pone.0113363-Granath1">[37]</xref>–<xref ref-type="bibr" rid="pone.0113363-Jaramillo2">[39]</xref></p>
<p>The only meta-analysis to assess the role of all three <italic>NOS3</italic> SNPs with respect to CAD reported association only in recessive genetic model of Glu298Asp, while dominant and allelic comparisons came out to be non-associated in the pooled analysis (all ethnicities combined). <xref ref-type="bibr" rid="pone.0113363-Li1">[40]</xref> On the other hand, lack of association with CAD was seen for all three genetic models of T786-C and 4b/a. <xref ref-type="bibr" rid="pone.0113363-Li1">[40]</xref> Since the publication of the aforementioned study, <xref ref-type="bibr" rid="pone.0113363-Li1">[40]</xref> a few more recent meta-analyses focusing on either one of the selected SNPs were published reporting varied results of either association or lack of association among different employed genetic models. <xref ref-type="bibr" rid="pone.0113363-Zhang1">[41]</xref>–<xref ref-type="bibr" rid="pone.0113363-Yang1">[44]</xref> None of them had strict criteria for inclusion of studies, which may have led to inaccurate results. Some of these published meta-analyses also included studies where genotype frequencies among controls deviated from Hardy-Weinberg equilibrium. Such deviation may hint a non-random inclusion of controls among the studies in question, which could have led to inaccurate results. Studies with several surrogate endpoints, such as “coronary artery spasm” and “heart failure”, were also included in these previously published meta-analyses. These endpoints may or may not correspond to the disease profile and pathology of CAD in general therefore such studies should have been ideally excluded. On the top of that, ethnic classifications in subgroup analyses were not appropriate in these meta-analyses and the studies were broadly and wrongly classified. We hypothesize that all these described factors may have resulted in biased effect sizes reported in all pooled as well as ethnic subgroups in these previously published meta-analyses. <xref ref-type="bibr" rid="pone.0113363-Li1">[40]</xref>–<xref ref-type="bibr" rid="pone.0113363-Yang1">[44]</xref> It is also noteworthy that no genome wide association study (GWAS) published till date has identified either of these selected SNPs as risk factors for CAD. Thus, a structured meta-analysis of published association studies for <italic>NOS3</italic> polymorphisms, which would aid to improve the existing understanding of these polymorphic forms of this gene in relation to CAD was warranted. Taking this as an objective, we conducted a systematic review and updated meta-analysis to ascertain the role of the three most common <italic>NOS3</italic> gene polymorphisms in CAD. We also tested their association separately among published studies originating predominantly from European, Middle Eastern, Asian, Asian-Indian and African ancestries.</p>
</sec></sec><sec id="s2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="s2a">
<title>Literature Search</title>
<p>The databases of the US National Institutes of Health (PubMed), EMBASE and a MEDLINE Scopus and Web of Knowledge were systematically searched for relevant articles published online by March 2014. Both medical search headings and open text fields were used to identify articles. We systematically searched various databases and the reference lists of the relevant publications using the combination of terms like ‘NOS3’ OR ‘eNOS’ OR ‘constitutive endothelial NOS’ OR ‘ecNOS’ OR ‘endothelial nitric oxide synthase’ OR ‘endothelial NO synthase’ paired with ‘atherosclerotic heart disease’ OR ‘coronary artery disease’ OR ‘CAD’ OR ‘MI’ OR ‘Myocardial Infarction’ OR ‘AMI’ OR Acute Myocardial Infarction OR ‘ACS’ OR ‘Acute Coronary Syndrome’ AND ‘polymorphism’ OR ‘mutation’ OR ‘gene polymorphism’ Or ‘SNP’ OR ‘Single Nucleotide Polymorphism’. The search in these databases was restricted to articles relating to humans, covering all relevant English language publications published up to March 2014. All references cited in the resulting studies and in previously published reviews on this topic were examined to identify additional work not indexed in internet databases. Papers without sufficient information were identified and their corresponding authors were contacted via at least three emails (spaced one week apart) requesting needed information. Publications whose corresponding authors did not respond were thenceforth not included. Since data from unpublished studies is unlikely to be trustworthy, we chose not to include it into this present meta-analysis. The decision to include studies was hierarchical; initially study titles, then abstracts and finally the full body of the text were assessed. The following information was recorded from the retrieved studies: author's names, publication year, country where the study was conducted, study design, inclusion criteria for CAD patients and normal controls, methods used for genotyping and the distribution of polymorphic genotypes and alleles in each group.</p>
<p>To be included in the meta-analysis, articles had to assess the association between CAD or MI patients and CAD free controls. Our selection criteria included studies that met all of the following criteria: (1) published in a peer-reviewed journal and independent studies using original data; (2) unrelated case-control or cohort studies; (3) providing complete data with genotype and allele frequencies to calculate the odds ratio (OR) with confidence interval (CI) and p values; (4) CAD patient diagnosis based on coronary angiography/clinical assessment and controls not being CAD patients; (5) all studies included had to be published in English language; and (6) all included studies had to have their genotype distribution among controls consistent with Hardy Weinberg approximations. We excluded the case reports, case studies and the studies not providing adequate information on selection criteria and the actual distribution of genotypes in each group. We also purposefully excluded studies with a surrogate endpoint such as “coronary artery spasm” or “heart failure”. Strict adherence to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses-PRISMA statement <xref ref-type="bibr" rid="pone.0113363-Panic1">[45]</xref> and the specific recommendations for genetic meta-analysis in the HuGE Review Handbook, version 1.0 was ensured.</p>
</sec><sec id="s2b">
<title>Data collection and Statistical Analysis</title>
<p>All required data along with genotypic distribution among cases and controls were recorded from publications (in duplicate) on a paper proforma. Later allele frequency was calculated manually and all the data was then transcribed on to a Microsoft Excel program on a computer. We checked departure from Hardy-Weinberg equilibrium (HWE) among control population for each included study using Michael H. Court's (2005–2008) online calculator (<ext-link ext-link-type="uri" xlink:href="http://www.tufts.edu/~mcourt01/Documents/Court%20lab%20-%20HW%20calculator.xls" xlink:type="simple">http://www.tufts.edu/~mcourt01/Documents/Court%20lab%20-%20HW%20calculator.xls</ext-link>). Studies with genotype frequency among controls yielding a p value of &lt;0.05, did not conform to HWE approximations and were thus excluded.</p>
<p>All calculations in this meta-analysis were carried out using Review Manager (<italic>RevMan</italic>) [Computer program]. Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. The extracted data from all publications were tested using previously described three genetic models i.e. dominant, recessive, and allelic model. <xref ref-type="bibr" rid="pone.0113363-Lewis1">[46]</xref> Bivariate and random or fixed effect models were used for calculating effect size (i.e. Odds ratios: ORs). For each study, individual and summary ORs and its 95% confidence intervals (CIs) were calculated (for all three genetic models), using either random (DerSimonian-Laird method) <xref ref-type="bibr" rid="pone.0113363-DerSimonian1">[47]</xref> or fixed effects model (Mantel-Haenszel method). <xref ref-type="bibr" rid="pone.0113363-Mantel1">[48]</xref> The pooled odds ratio (OR) with a corresponding 95% confidence interval (CI) was used to assess the degree of association. Based on the individual ORs, the pooled OR was estimated, the significance of which was determined by <italic>Z</italic> test (P&lt;0.05 was considered statistically significant). Summary P value and Z value was also calculated (as listed) for each study group, for each genetic model to express the significance and degree of association. Existence of heterogeneity was tested using a Q test. It was performed using Higgins <italic>I<sup>2</sup></italic> statistics (<italic>I<sup>2</sup></italic>) and Cochran's Q statistics (P<sub>Q</sub>) for each group of studies. Those resulting with <italic>I<sup>2</sup></italic>&gt;50% and P<sub>Q</sub>&lt;0.01 were identified as a heterogeneous group. Low, moderate and high heterogeneity was defined according to previously published estimates <xref ref-type="bibr" rid="pone.0113363-Higgins1">[49]</xref> using cut off points of <italic>I<sup>2</sup></italic> values as 25%, 50% and 75%. Using this calculation, <italic>I<sup>2</sup></italic> value of &lt;50% and P<sub>Q</sub>&gt;0.01 was considered the criterion for selecting fixed effects for analysis. On the other hand, random effects were used for analyses for groups having <italic>I<sup>2</sup></italic> values of &gt;50%. In order to define the sources of heterogeneity, subgroup analysis was performed. The subgroups were classified according to predominant ancestry among which the study was conducted. Publication bias was identified by examining Begg's funnel plots <xref ref-type="bibr" rid="pone.0113363-Begg1">[50]</xref> and by estimates from the Egger's test. <xref ref-type="bibr" rid="pone.0113363-Egger1">[51]</xref> Sensitivity analysis was also performed in each ancestral group in every studied genetic model.</p>
<p>Adjustment of environmental factors is an important aspect in conducting meta-analysis of genetic association studies. However, since genetic variation among individuals is assigned at the time of birth, environmental factors like diet and lifestyle which an individual experiences thenceforth have no role in changing that attribute. <xref ref-type="bibr" rid="pone.0113363-Clayton1">[52]</xref> These factors, though can have a huge impact over the phenotype, cannot confound to the association between the genotype and the resultant phenotype. It is almost impossible to adjust environmental factors in meta-analyses of this nature. The full data is not available for every included manuscript and we have to work with only the published information. Although in an attempt to adjust the environmental factors, we stratified the studies according to predominant ethnicity among which it was conducted, which was the most we could have done.</p>
</sec></sec><sec id="s3">
<title>Results</title>
<p>The preliminary web search identified a total of 452 potential publications, of which 336 were immediately excluded because of obvious irrelevance after studying their titles and/or abstracts. A total of 116 articles were selected to be reviewed in full text, among which 27 articles were excluded as they met our previously described exclusion criteria. We finally selected 89 articles, which reported 132 separate studies, involving a total sample size of 69,235 to be used in the present meta-analysis. This process is explained in the form of a flowchart in <xref ref-type="fig" rid="pone-0113363-g001"><bold>Figure 1</bold></xref>. The included studies were further broadly classified according to the predominant ancestry among which they were conducted. Accordingly the studies were included in one of the five ancestral groups, viz. European, Middle Eastern, Asian, Asian-Indian or African. The general characteristics of studies classified in each ancestral group, reporting association studies involving any of the three SNPs, along with an estimate of total sample tested are depicted in <xref ref-type="table" rid="pone-0113363-t001"><bold>Table 1</bold></xref>. Among these included studies, cases were generally recruited in referral centres with documented CAD or MI or ACS, and the controls were without any direct evidence of overt disease. The number of cases among all selected studies varied from 22 to 2,085, while the numbers of controls varied from 21 to 3,918.</p>
<fig id="pone-0113363-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0113363.g001</object-id><label>Figure 1</label><caption>
<title>Selection of studies for inclusion.</title>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0113363.g001" position="float" xlink:type="simple"/></fig><table-wrap id="pone-0113363-t001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0113363.t001</object-id><label>Table 1</label><caption>
<title>Published association studies included in the present meta-analysis.</title>
</caption><alternatives><graphic id="pone-0113363-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0113363.t001" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">Study</td>
<td align="left" rowspan="1" colspan="1">Year</td>
<td align="left" rowspan="1" colspan="1">Country</td>
<td align="left" rowspan="1" colspan="1">SNPs studied</td>
<td colspan="3" align="left" rowspan="1">MAF (Cases/Controls)</td>
<td align="left" rowspan="1" colspan="1">Total sample size (for each SNP)</td>
<td align="left" rowspan="1" colspan="1">Outcome</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
</td>
<td align="left" rowspan="1" colspan="1">
</td>
<td align="left" rowspan="1" colspan="1">
</td>
<td align="left" rowspan="1" colspan="1">
</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">4b/a</td>
<td align="left" rowspan="1" colspan="1">T786-C</td>
<td align="left" rowspan="1" colspan="1">
</td>
<td align="left" rowspan="1" colspan="1">
</td>
</tr>
</thead>
<tbody>
<tr>
<td colspan="3" align="left" rowspan="1"><bold>EUROPEAN ANCESTRY GROUP</bold></td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Wang et al. <xref ref-type="bibr" rid="pone.0113363-Wang1">[33]</xref></td>
<td align="left" rowspan="1" colspan="1">1996</td>
<td align="left" rowspan="1" colspan="1">Australia</td>
<td align="left" rowspan="1" colspan="1">4b/a</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.14/0.17</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">702</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Cai et al. <xref ref-type="bibr" rid="pone.0113363-Cai1">[18]</xref></td>
<td align="left" rowspan="1" colspan="1">1999</td>
<td align="left" rowspan="1" colspan="1">Australia</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.32/0.36</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">763</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Hingorani et al.(CHAOS) <xref ref-type="bibr" rid="pone.0113363-Hingorani1">[3]</xref></td>
<td align="left" rowspan="1" colspan="1">1999</td>
<td align="left" rowspan="1" colspan="1">UK</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.48/0.31</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">436</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Hingorani et al.(CHAOS-2) <xref ref-type="bibr" rid="pone.0113363-Hingorani1">[3]</xref></td>
<td align="left" rowspan="1" colspan="1">1999</td>
<td align="left" rowspan="1" colspan="1">UK</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.40/0.31</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">432</td>
<td align="left" rowspan="1" colspan="1">MI</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Poirier et al.(1) <xref ref-type="bibr" rid="pone.0113363-Poirier1">[38]</xref></td>
<td align="left" rowspan="1" colspan="1">1999</td>
<td align="left" rowspan="1" colspan="1">Ireland</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.43/0.39</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">318</td>
<td align="left" rowspan="1" colspan="1">MI</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Poirier et al.(2) <xref ref-type="bibr" rid="pone.0113363-Poirier1">[38]</xref></td>
<td align="left" rowspan="1" colspan="1">1999</td>
<td align="left" rowspan="1" colspan="1">France</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.34/0.39</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">789</td>
<td align="left" rowspan="1" colspan="1">MI</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Fowkes et al. <xref ref-type="bibr" rid="pone.0113363-Fowkes1">[99]</xref></td>
<td align="left" rowspan="1" colspan="1">2000</td>
<td align="left" rowspan="1" colspan="1">UK</td>
<td align="left" rowspan="1" colspan="1">4b/a</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.16/0.12</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">437</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Pulkkinen et al. <xref ref-type="bibr" rid="pone.0113363-Pulkkinen2">[100]</xref></td>
<td align="left" rowspan="1" colspan="1">2000</td>
<td align="left" rowspan="1" colspan="1">Finland</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp, 4b/a</td>
<td align="left" rowspan="1" colspan="1">0.32/0.30</td>
<td align="left" rowspan="1" colspan="1">0.20/0.16</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">669 for each</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Sigusch et al. <xref ref-type="bibr" rid="pone.0113363-Sigusch1">[101]</xref></td>
<td align="left" rowspan="1" colspan="1">2000</td>
<td align="left" rowspan="1" colspan="1">Germany</td>
<td align="left" rowspan="1" colspan="1">4b/a</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.15/0.17</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">1043</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Alvarez et al. <xref ref-type="bibr" rid="pone.0113363-Alvarez1">[27]</xref></td>
<td align="left" rowspan="1" colspan="1">2001</td>
<td align="left" rowspan="1" colspan="1">Spain</td>
<td align="left" rowspan="1" colspan="1">4b/a, T786-C</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.12/0.14</td>
<td align="left" rowspan="1" colspan="1">0.46/0.37</td>
<td align="left" rowspan="1" colspan="1">470 for each</td>
<td align="left" rowspan="1" colspan="1">PCAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Granath et al. <xref ref-type="bibr" rid="pone.0113363-Granath1">[37]</xref></td>
<td align="left" rowspan="1" colspan="1">2001</td>
<td align="left" rowspan="1" colspan="1">Australia</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp, 4b/a, T786-C</td>
<td align="left" rowspan="1" colspan="1">0.33/0.34</td>
<td align="left" rowspan="1" colspan="1">0.14/0.15</td>
<td align="left" rowspan="1" colspan="1">0.38/0.38</td>
<td align="left" rowspan="1" colspan="1">1194, 1187 and 1196 respectively</td>
<td align="left" rowspan="1" colspan="1">PCAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Gardemann et al. <xref ref-type="bibr" rid="pone.0113363-Gardemann1">[2]</xref></td>
<td align="left" rowspan="1" colspan="1">2002</td>
<td align="left" rowspan="1" colspan="1">Germany</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp, 4b/a</td>
<td align="left" rowspan="1" colspan="1">0.33/0.31</td>
<td align="left" rowspan="1" colspan="1">0.14/0.16</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">3250 and 3215 respectively for each</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Colombo et al. <xref ref-type="bibr" rid="pone.0113363-Colombo2">[5]</xref></td>
<td align="left" rowspan="1" colspan="1">2003</td>
<td align="left" rowspan="1" colspan="1">Italy</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp, T786-C</td>
<td align="left" rowspan="1" colspan="1">0.38/0.31</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.51/0.40</td>
<td align="left" rowspan="1" colspan="1">415 and 374 respectively for each</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Schmoelzer et al. <xref ref-type="bibr" rid="pone.0113363-Schmoelzer1">[20]</xref></td>
<td align="left" rowspan="1" colspan="1">2003</td>
<td align="left" rowspan="1" colspan="1">Austria</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.34/0.31</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">488</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Agema et al. <xref ref-type="bibr" rid="pone.0113363-Agema1">[54]</xref></td>
<td align="left" rowspan="1" colspan="1">2004</td>
<td align="left" rowspan="1" colspan="1">Netherlands</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp, 4b/a, T786-C</td>
<td align="left" rowspan="1" colspan="1">0.32/0.39</td>
<td align="left" rowspan="1" colspan="1">0.15/0.10</td>
<td align="left" rowspan="1" colspan="1">0.38/0.36</td>
<td align="left" rowspan="1" colspan="1">1329, 1218 and 1096 respectively for each</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Fatini et al. <xref ref-type="bibr" rid="pone.0113363-Fatini1">[55]</xref></td>
<td align="left" rowspan="1" colspan="1">2004</td>
<td align="left" rowspan="1" colspan="1">Italy</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp, 4b/a, T786-C</td>
<td align="left" rowspan="1" colspan="1">0.39/0/33</td>
<td align="left" rowspan="1" colspan="1">0.19/0.15</td>
<td align="left" rowspan="1" colspan="1">0.48/0.39</td>
<td align="left" rowspan="1" colspan="1">1014 for each</td>
<td align="left" rowspan="1" colspan="1">ACS</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Letonja et al. <xref ref-type="bibr" rid="pone.0113363-Letonja1">[102]</xref></td>
<td align="left" rowspan="1" colspan="1">2004</td>
<td align="left" rowspan="1" colspan="1">Slovenia</td>
<td align="left" rowspan="1" colspan="1">4b/a</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.17/0.19</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">260</td>
<td align="left" rowspan="1" colspan="1">PCAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Antoniades et al. <xref ref-type="bibr" rid="pone.0113363-Antoniades1">[56]</xref></td>
<td align="left" rowspan="1" colspan="1">2005</td>
<td align="left" rowspan="1" colspan="1">Greece</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.36/0.30</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">747</td>
<td align="left" rowspan="1" colspan="1">MI</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Milutinovic et al. <xref ref-type="bibr" rid="pone.0113363-Milutinovic1">[103]</xref></td>
<td align="left" rowspan="1" colspan="1">2005</td>
<td align="left" rowspan="1" colspan="1">Slovenia</td>
<td align="left" rowspan="1" colspan="1">4b/a</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.19/0.21</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">403</td>
<td align="left" rowspan="1" colspan="1">PCAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Rao et al.(1) <xref ref-type="bibr" rid="pone.0113363-Rao1">[104]</xref></td>
<td align="left" rowspan="1" colspan="1">2005</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">4b/a</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.15/0.14</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">151</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Rios et al. <xref ref-type="bibr" rid="pone.0113363-Rios1">[28]</xref></td>
<td align="left" rowspan="1" colspan="1">2005</td>
<td align="left" rowspan="1" colspan="1">Brazil</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp, T786-C</td>
<td align="left" rowspan="1" colspan="1">0.37/0.32</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.44/0.34</td>
<td align="left" rowspan="1" colspan="1">497 for each</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Dosenko et al. <xref ref-type="bibr" rid="pone.0113363-Dosenko1">[91]</xref></td>
<td align="left" rowspan="1" colspan="1">2006</td>
<td align="left" rowspan="1" colspan="1">Ukraine</td>
<td align="left" rowspan="1" colspan="1">4b/a, T786-C</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.20/0.21</td>
<td align="left" rowspan="1" colspan="1">0.34/0.29</td>
<td align="left" rowspan="1" colspan="1">304 for each</td>
<td align="left" rowspan="1" colspan="1">ACS</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Jaramillo et.al. <xref ref-type="bibr" rid="pone.0113363-Jaramillo1">[21]</xref></td>
<td align="left" rowspan="1" colspan="1">2006</td>
<td align="left" rowspan="1" colspan="1">Chile</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.21/0.15</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">184</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Rios et al.(1) <xref ref-type="bibr" rid="pone.0113363-Rios2">[57]</xref></td>
<td align="left" rowspan="1" colspan="1">2007</td>
<td align="left" rowspan="1" colspan="1">Brazil</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp, 4b/a</td>
<td align="left" rowspan="1" colspan="1">0.29/0.26</td>
<td align="left" rowspan="1" colspan="1">0.18/0.23</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">447 for each</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Sampaio et al. <xref ref-type="bibr" rid="pone.0113363-Sampaio1">[58]</xref></td>
<td align="left" rowspan="1" colspan="1">2007</td>
<td align="left" rowspan="1" colspan="1">Brazil</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp, 4b/a, T786-C</td>
<td align="left" rowspan="1" colspan="1">0.31/0.28</td>
<td align="left" rowspan="1" colspan="1">0.16/0.19</td>
<td align="left" rowspan="1" colspan="1">0.25/0.37</td>
<td align="left" rowspan="1" colspan="1">219 for each</td>
<td align="left" rowspan="1" colspan="1">PMI</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Andrikopoulos et al. <xref ref-type="bibr" rid="pone.0113363-Andrikopoulos1">[59]</xref></td>
<td align="left" rowspan="1" colspan="1">2008</td>
<td align="left" rowspan="1" colspan="1">Greece</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.33/0.31</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">2329</td>
<td align="left" rowspan="1" colspan="1">AMI</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Jaramillo et al. <xref ref-type="bibr" rid="pone.0113363-Jaramillo3">[92]</xref></td>
<td align="left" rowspan="1" colspan="1">2008</td>
<td align="left" rowspan="1" colspan="1">Chile</td>
<td align="left" rowspan="1" colspan="1">T786-C</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.24/0.22</td>
<td align="left" rowspan="1" colspan="1">221</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Szperl et al. <xref ref-type="bibr" rid="pone.0113363-Szperl1">[60]</xref></td>
<td align="left" rowspan="1" colspan="1">2008</td>
<td align="left" rowspan="1" colspan="1">Poland</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.32/0.27</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">418</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Vasilakou et al. <xref ref-type="bibr" rid="pone.0113363-Vasilakou1">[61]</xref></td>
<td align="left" rowspan="1" colspan="1">2008</td>
<td align="left" rowspan="1" colspan="1">Greece</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp, 4b/a</td>
<td align="left" rowspan="1" colspan="1">0.27/0.30</td>
<td align="left" rowspan="1" colspan="1">0.19/0.15</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">370 for each</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Gluba et al. <xref ref-type="bibr" rid="pone.0113363-Gluba1">[62]</xref></td>
<td align="left" rowspan="1" colspan="1">2009</td>
<td align="left" rowspan="1" colspan="1">Poland</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp, T786-C</td>
<td align="left" rowspan="1" colspan="1">0.50/0.54</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.36/0.38</td>
<td align="left" rowspan="1" colspan="1">412 for each</td>
<td align="left" rowspan="1" colspan="1">PCAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Kincl et al. <xref ref-type="bibr" rid="pone.0113363-Kincl1">[105]</xref></td>
<td align="left" rowspan="1" colspan="1">2009</td>
<td align="left" rowspan="1" colspan="1">Czech republic</td>
<td align="left" rowspan="1" colspan="1">4b/a</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.18/0.18</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">1161</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Meluzin et al. <xref ref-type="bibr" rid="pone.0113363-Meluzin1">[93]</xref></td>
<td align="left" rowspan="1" colspan="1">2009</td>
<td align="left" rowspan="1" colspan="1">Czech republic</td>
<td align="left" rowspan="1" colspan="1">4b/a, T786-C</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.18/0.15</td>
<td align="left" rowspan="1" colspan="1">0.38/0.32</td>
<td align="left" rowspan="1" colspan="1">419 for each</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Dafni et al. <xref ref-type="bibr" rid="pone.0113363-Dafni1">[15]</xref></td>
<td align="left" rowspan="1" colspan="1">2010</td>
<td align="left" rowspan="1" colspan="1">Greece</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.36/0.29</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">422</td>
<td align="left" rowspan="1" colspan="1">MI</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Isordia-Salas et al. <xref ref-type="bibr" rid="pone.0113363-IsordiaSalas1">[63]</xref></td>
<td align="left" rowspan="1" colspan="1">2010</td>
<td align="left" rowspan="1" colspan="1">Mexico</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.25/0.14</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">360</td>
<td align="left" rowspan="1" colspan="1">PMI</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Jaramillo et al. <xref ref-type="bibr" rid="pone.0113363-Jaramillo2">[39]</xref></td>
<td align="left" rowspan="1" colspan="1">2010</td>
<td align="left" rowspan="1" colspan="1">Chile</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp, 4b/a, T786-C</td>
<td align="left" rowspan="1" colspan="1">0.21/0.18</td>
<td align="left" rowspan="1" colspan="1">0.08/0.08</td>
<td align="left" rowspan="1" colspan="1">0.24/0.22</td>
<td align="left" rowspan="1" colspan="1">224 for each</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ragia et al. <xref ref-type="bibr" rid="pone.0113363-Ragia1">[32]</xref></td>
<td align="left" rowspan="1" colspan="1">2010</td>
<td align="left" rowspan="1" colspan="1">Greece</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp, T786-C</td>
<td align="left" rowspan="1" colspan="1">0.31/0.32</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.44/0.47</td>
<td align="left" rowspan="1" colspan="1">309</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">da Costa Escobar Piccoli et al. <xref ref-type="bibr" rid="pone.0113363-daCostaEscobarPiccoli1">[64]</xref></td>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">Brazil</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp, 4b/a, T786-C</td>
<td align="left" rowspan="1" colspan="1">0.34/0.26</td>
<td align="left" rowspan="1" colspan="1">0.22/0.21</td>
<td align="left" rowspan="1" colspan="1">0.36/0.33</td>
<td align="left" rowspan="1" colspan="1">241, 240 and 246 respectively for each</td>
<td align="left" rowspan="1" colspan="1">ACS</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Zigra et al. <xref ref-type="bibr" rid="pone.0113363-Zigra1">[65]</xref></td>
<td align="left" rowspan="1" colspan="1">2013</td>
<td align="left" rowspan="1" colspan="1">Greece</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp, T786-C</td>
<td align="left" rowspan="1" colspan="1">0.32/0.31</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.39/0.19</td>
<td align="left" rowspan="1" colspan="1">210</td>
<td align="left" rowspan="1" colspan="1">PMI</td>
</tr>
<tr>
<td colspan="3" align="left" rowspan="1"><bold>MIDDLE EASTERN ANCESTRY GROUP</bold></td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Aras et al. <xref ref-type="bibr" rid="pone.0113363-Aras1">[66]</xref></td>
<td align="left" rowspan="1" colspan="1">2002</td>
<td align="left" rowspan="1" colspan="1">Turkey</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.33/0.28</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">398</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Cine et al. <xref ref-type="bibr" rid="pone.0113363-Cine1">[34]</xref></td>
<td align="left" rowspan="1" colspan="1">2002</td>
<td align="left" rowspan="1" colspan="1">Turkey</td>
<td align="left" rowspan="1" colspan="1">4b/a</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.18/0.10</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">513</td>
<td align="left" rowspan="1" colspan="1">MI</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Afrasyap et al. <xref ref-type="bibr" rid="pone.0113363-Afrasyap1">[67]</xref></td>
<td align="left" rowspan="1" colspan="1">2004</td>
<td align="left" rowspan="1" colspan="1">Turkey</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.34/0.30</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">400</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Berdeli et al. <xref ref-type="bibr" rid="pone.0113363-Berdeli1">[68]</xref></td>
<td align="left" rowspan="1" colspan="1">2005</td>
<td align="left" rowspan="1" colspan="1">Turkey</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.46/0.17</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">198</td>
<td align="left" rowspan="1" colspan="1">PCAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Cam et al. <xref ref-type="bibr" rid="pone.0113363-Cam1">[69]</xref></td>
<td align="left" rowspan="1" colspan="1">2005</td>
<td align="left" rowspan="1" colspan="1">Turkey</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.46/0.17</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">198</td>
<td align="left" rowspan="1" colspan="1">PCAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Matyar et al. <xref ref-type="bibr" rid="pone.0113363-Matyar1">[106]</xref></td>
<td align="left" rowspan="1" colspan="1">2005</td>
<td align="left" rowspan="1" colspan="1">Turkey</td>
<td align="left" rowspan="1" colspan="1">4b/a</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.21/0.14</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">266</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Agirbasli et al. <xref ref-type="bibr" rid="pone.0113363-Agirbasli1">[107]</xref></td>
<td align="left" rowspan="1" colspan="1">2006</td>
<td align="left" rowspan="1" colspan="1">Turkey</td>
<td align="left" rowspan="1" colspan="1">4b/a</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.14/0.10</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">204</td>
<td align="left" rowspan="1" colspan="1">PCAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Kerkeni et al. <xref ref-type="bibr" rid="pone.0113363-Kerkeni1">[70]</xref></td>
<td align="left" rowspan="1" colspan="1">2006</td>
<td align="left" rowspan="1" colspan="1">Tunisia</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.33/0.22</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">220</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Salimi et al. <xref ref-type="bibr" rid="pone.0113363-Salimi3">[109]</xref></td>
<td align="left" rowspan="1" colspan="1">2006</td>
<td align="left" rowspan="1" colspan="1">Iran</td>
<td align="left" rowspan="1" colspan="1">4b/a</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.17/0.10</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">299</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Tangurek et al. <xref ref-type="bibr" rid="pone.0113363-Tangurek1">[94]</xref></td>
<td align="left" rowspan="1" colspan="1">2006</td>
<td align="left" rowspan="1" colspan="1">Turkey</td>
<td align="left" rowspan="1" colspan="1">T786-C</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.37/0.26</td>
<td align="left" rowspan="1" colspan="1">211</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Jemaa et al. <xref ref-type="bibr" rid="pone.0113363-Jemaa1">[110]</xref></td>
<td align="left" rowspan="1" colspan="1">2007</td>
<td align="left" rowspan="1" colspan="1">Tunisia</td>
<td align="left" rowspan="1" colspan="1">4b/a</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.22/0.14</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">560</td>
<td align="left" rowspan="1" colspan="1">MI</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ciftci et al. <xref ref-type="bibr" rid="pone.0113363-Ciftci1">[95]</xref></td>
<td align="left" rowspan="1" colspan="1">2008</td>
<td align="left" rowspan="1" colspan="1">Turkey</td>
<td align="left" rowspan="1" colspan="1">T786-C</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.33/0.19</td>
<td align="left" rowspan="1" colspan="1">61</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Alp et al. <xref ref-type="bibr" rid="pone.0113363-Alp1">[23]</xref></td>
<td align="left" rowspan="1" colspan="1">2009</td>
<td align="left" rowspan="1" colspan="1">Turkey</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp, T786-C</td>
<td align="left" rowspan="1" colspan="1">0.28/0.25</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.29/0.29</td>
<td align="left" rowspan="1" colspan="1">268 for each</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Alkharfy et al. <xref ref-type="bibr" rid="pone.0113363-Alkharfy1">[71]</xref></td>
<td align="left" rowspan="1" colspan="1">2010</td>
<td align="left" rowspan="1" colspan="1">Saudi Arabia</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.31/0.19</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">287</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Bor-Kucukatay et al. <xref ref-type="bibr" rid="pone.0113363-BorKucukatay1">[14]</xref></td>
<td align="left" rowspan="1" colspan="1">2010</td>
<td align="left" rowspan="1" colspan="1">Turkey</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.25/0.18</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">157</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Salimi et al. <xref ref-type="bibr" rid="pone.0113363-Salimi1">[16]</xref></td>
<td align="left" rowspan="1" colspan="1">2010</td>
<td align="left" rowspan="1" colspan="1">Iran</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.32/0.23</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">502</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Agirbasli et al. <xref ref-type="bibr" rid="pone.0113363-Agirbasli2">[108]</xref></td>
<td align="left" rowspan="1" colspan="1">2011</td>
<td align="left" rowspan="1" colspan="1">Turkey</td>
<td align="left" rowspan="1" colspan="1">4b/a</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.13/0.15</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">180</td>
<td align="left" rowspan="1" colspan="1">PCAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Motawi et al. <xref ref-type="bibr" rid="pone.0113363-Motawi1">[72]</xref></td>
<td align="left" rowspan="1" colspan="1">2011</td>
<td align="left" rowspan="1" colspan="1">Egypt</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.37/0.34</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">150</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Gad et al. <xref ref-type="bibr" rid="pone.0113363-Gad1">[73]</xref></td>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">Egypt</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.27/0.25</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">205</td>
<td align="left" rowspan="1" colspan="1">AMI</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Rahimi et al. <xref ref-type="bibr" rid="pone.0113363-Rahimi1">[74]</xref></td>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">Iran</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.26/0.26</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">309</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Salimi et al. <xref ref-type="bibr" rid="pone.0113363-Salimi2">[17]</xref></td>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">Iran</td>
<td align="left" rowspan="1" colspan="1">T786-C</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.33/0.20</td>
<td align="left" rowspan="1" colspan="1">502</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Abdel Aziz et al. <xref ref-type="bibr" rid="pone.0113363-AbdelAziz1">[75]</xref></td>
<td align="left" rowspan="1" colspan="1">2013</td>
<td align="left" rowspan="1" colspan="1">Egypt</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.39/0.26</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">235</td>
<td align="left" rowspan="1" colspan="1">PCAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ekmekci et al. <xref ref-type="bibr" rid="pone.0113363-Ekmekci1">[111]</xref></td>
<td align="left" rowspan="1" colspan="1">2013</td>
<td align="left" rowspan="1" colspan="1">Turkey</td>
<td align="left" rowspan="1" colspan="1">4b/a</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.20/0.09</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">120</td>
<td align="left" rowspan="1" colspan="1">PCAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Kallel et al. <xref ref-type="bibr" rid="pone.0113363-Kallel1">[76]</xref></td>
<td align="left" rowspan="1" colspan="1">2013</td>
<td align="left" rowspan="1" colspan="1">Tunisia</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp, 4b/a, T786-C</td>
<td align="left" rowspan="1" colspan="1">0.26/0.26</td>
<td align="left" rowspan="1" colspan="1">0.22/0.14</td>
<td align="left" rowspan="1" colspan="1">0.37/0.35</td>
<td align="left" rowspan="1" colspan="1">528 for each</td>
<td align="left" rowspan="1" colspan="1">MI</td>
</tr>
<tr>
<td colspan="3" align="left" rowspan="1"><bold>ASIAN ANCESTRY GROUP</bold></td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Hibi et al. <xref ref-type="bibr" rid="pone.0113363-Hibi1">[11]</xref></td>
<td align="left" rowspan="1" colspan="1">1998</td>
<td align="left" rowspan="1" colspan="1">Japan</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp, 4b/a</td>
<td align="left" rowspan="1" colspan="1">0.09/0.09</td>
<td align="left" rowspan="1" colspan="1">0.12/0.11</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">583 for each</td>
<td align="left" rowspan="1" colspan="1">AMI</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Ichihara et al. <xref ref-type="bibr" rid="pone.0113363-Ichihara1">[35]</xref></td>
<td align="left" rowspan="1" colspan="1">1998</td>
<td align="left" rowspan="1" colspan="1">Japan</td>
<td align="left" rowspan="1" colspan="1">4b/a</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.14/0.10</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">1005</td>
<td align="left" rowspan="1" colspan="1">MI</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Odawara et al. <xref ref-type="bibr" rid="pone.0113363-Odawara1">[112]</xref></td>
<td align="left" rowspan="1" colspan="1">1998</td>
<td align="left" rowspan="1" colspan="1">Japan</td>
<td align="left" rowspan="1" colspan="1">4b/a</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">013/0.08</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">164</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Shimasaki et al. <xref ref-type="bibr" rid="pone.0113363-Shimasaki1">[10]</xref></td>
<td align="left" rowspan="1" colspan="1">1998</td>
<td align="left" rowspan="1" colspan="1">Japan</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.11/0.07</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">892</td>
<td align="left" rowspan="1" colspan="1">MI</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Nakagami et al. <xref ref-type="bibr" rid="pone.0113363-Nakagami1">[113]</xref></td>
<td align="left" rowspan="1" colspan="1">1999</td>
<td align="left" rowspan="1" colspan="1">Japan</td>
<td align="left" rowspan="1" colspan="1">4b/a</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.25/0.16</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">74</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Nakayama et al. <xref ref-type="bibr" rid="pone.0113363-Nakayama2">[31]</xref></td>
<td align="left" rowspan="1" colspan="1">2000</td>
<td align="left" rowspan="1" colspan="1">Japan</td>
<td align="left" rowspan="1" colspan="1">T786-C</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.12/0.04</td>
<td align="left" rowspan="1" colspan="1">554</td>
<td align="left" rowspan="1" colspan="1">MI</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Park et al. <xref ref-type="bibr" rid="pone.0113363-Park1">[36]</xref></td>
<td align="left" rowspan="1" colspan="1">2000</td>
<td align="left" rowspan="1" colspan="1">Korea</td>
<td align="left" rowspan="1" colspan="1">4b/a</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.14/0.12</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">327</td>
<td align="left" rowspan="1" colspan="1">AMI</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Yoon et al. <xref ref-type="bibr" rid="pone.0113363-Yoon1">[77]</xref></td>
<td align="left" rowspan="1" colspan="1">2000</td>
<td align="left" rowspan="1" colspan="1">Korea</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.08/0.07</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">238</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Lee et al. <xref ref-type="bibr" rid="pone.0113363-Lee1">[114]</xref></td>
<td align="left" rowspan="1" colspan="1">2001</td>
<td align="left" rowspan="1" colspan="1">Korea</td>
<td align="left" rowspan="1" colspan="1">4b/a</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.10/0.12</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">520</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Takagi et al. <xref ref-type="bibr" rid="pone.0113363-Takagi1">[96]</xref></td>
<td align="left" rowspan="1" colspan="1">2001</td>
<td align="left" rowspan="1" colspan="1">Japan</td>
<td align="left" rowspan="1" colspan="1">T786-C</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.12/0.11</td>
<td align="left" rowspan="1" colspan="1">4372</td>
<td align="left" rowspan="1" colspan="1">MI</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Wang et al. <xref ref-type="bibr" rid="pone.0113363-Wang2">[78]</xref></td>
<td align="left" rowspan="1" colspan="1">2001</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.10/0.10</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">436</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Hwang et al. <xref ref-type="bibr" rid="pone.0113363-Hwang1">[115]</xref></td>
<td align="left" rowspan="1" colspan="1">2002</td>
<td align="left" rowspan="1" colspan="1">Taiwan</td>
<td align="left" rowspan="1" colspan="1">4b/a</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.11/0.10</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">219</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Jo et al. <xref ref-type="bibr" rid="pone.0113363-Jo1">[79]</xref></td>
<td align="left" rowspan="1" colspan="1">2006</td>
<td align="left" rowspan="1" colspan="1">Korea</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp, T786-C</td>
<td align="left" rowspan="1" colspan="1">0.10/0.09</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.16/0.11</td>
<td align="left" rowspan="1" colspan="1">932 for each</td>
<td align="left" rowspan="1" colspan="1">MI</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Kim et al. <xref ref-type="bibr" rid="pone.0113363-Kim1">[22]</xref></td>
<td align="left" rowspan="1" colspan="1">2007</td>
<td align="left" rowspan="1" colspan="1">Korea</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp, 4b/a, T786-C</td>
<td align="left" rowspan="1" colspan="1">0.09/0.09</td>
<td align="left" rowspan="1" colspan="1">0.13/0.09</td>
<td align="left" rowspan="1" colspan="1">0.13/0.09</td>
<td align="left" rowspan="1" colspan="1">366, 358 and 367 respectively for each</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Lin et al. <xref ref-type="bibr" rid="pone.0113363-Lin1">[80]</xref></td>
<td align="left" rowspan="1" colspan="1">2008</td>
<td align="left" rowspan="1" colspan="1">Taiwan</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp, 4b/a</td>
<td align="left" rowspan="1" colspan="1">0.42/0.22</td>
<td align="left" rowspan="1" colspan="1">0.14/0.11</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">198</td>
<td align="left" rowspan="1" colspan="1">CVD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Tamemoto et al. <xref ref-type="bibr" rid="pone.0113363-Tamemoto1">[81]</xref></td>
<td align="left" rowspan="1" colspan="1">2008</td>
<td align="left" rowspan="1" colspan="1">Japan</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.18/0.06</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">337</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Bae et al. <xref ref-type="bibr" rid="pone.0113363-Bae1">[82]</xref></td>
<td align="left" rowspan="1" colspan="1">2010</td>
<td align="left" rowspan="1" colspan="1">Korea</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp, 4b/a, T786-C</td>
<td align="left" rowspan="1" colspan="1">0.09/0.08</td>
<td align="left" rowspan="1" colspan="1">0.12/0.09</td>
<td align="left" rowspan="1" colspan="1">0.12/0.08</td>
<td align="left" rowspan="1" colspan="1">388 for each</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Han et al. <xref ref-type="bibr" rid="pone.0113363-Han1">[97]</xref></td>
<td align="left" rowspan="1" colspan="1">2010</td>
<td align="left" rowspan="1" colspan="1">China</td>
<td align="left" rowspan="1" colspan="1">T786-C</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.23/0.15</td>
<td align="left" rowspan="1" colspan="1">622</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Min et al. <xref ref-type="bibr" rid="pone.0113363-Min1">[83]</xref></td>
<td align="left" rowspan="1" colspan="1">2010</td>
<td align="left" rowspan="1" colspan="1">Korea</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.11/0.04</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">438</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td colspan="3" align="left" rowspan="1"><bold>ASIAN-INDIAN ANCESTRY GROUP</bold></td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Mathew et al. <xref ref-type="bibr" rid="pone.0113363-Mathew1">[84]</xref></td>
<td align="left" rowspan="1" colspan="1">2008</td>
<td align="left" rowspan="1" colspan="1">India</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.15/0.12</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">200</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Angeline et al. <xref ref-type="bibr" rid="pone.0113363-Angeline1">[13]</xref></td>
<td align="left" rowspan="1" colspan="1">2010</td>
<td align="left" rowspan="1" colspan="1">India</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.29/0.17</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">200</td>
<td align="left" rowspan="1" colspan="1">AMI</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Bhanushali et al. <xref ref-type="bibr" rid="pone.0113363-Bhanushali1">[85]</xref></td>
<td align="left" rowspan="1" colspan="1">2010</td>
<td align="left" rowspan="1" colspan="1">India</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.18/0.17</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">200</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Gururajan et al. <xref ref-type="bibr" rid="pone.0113363-Gururajan1">[116]</xref></td>
<td align="left" rowspan="1" colspan="1">2010</td>
<td align="left" rowspan="1" colspan="1">India</td>
<td align="left" rowspan="1" colspan="1">4b/a</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.28/0.14</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">206</td>
<td align="left" rowspan="1" colspan="1">ACS</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Saini et al. <xref ref-type="bibr" rid="pone.0113363-Saini1">[86]</xref></td>
<td align="left" rowspan="1" colspan="1">2011</td>
<td align="left" rowspan="1" colspan="1">India</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.12/0.06</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">110</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Rai et al. <xref ref-type="bibr" rid="pone.0113363-Rai1">[87]</xref></td>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">India</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.21/0.17</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">427</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Saini et al. <xref ref-type="bibr" rid="pone.0113363-Saini2">[88]</xref></td>
<td align="left" rowspan="1" colspan="1">2012</td>
<td align="left" rowspan="1" colspan="1">India</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp</td>
<td align="left" rowspan="1" colspan="1">0.10/0.06</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">110</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Arun Kumar et al. <xref ref-type="bibr" rid="pone.0113363-ArunKumar1">[89]</xref></td>
<td align="left" rowspan="1" colspan="1">2013</td>
<td align="left" rowspan="1" colspan="1">India</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp, T786-C</td>
<td align="left" rowspan="1" colspan="1">0.15/0.15</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.23/0.20</td>
<td align="left" rowspan="1" colspan="1">887 for each</td>
<td align="left" rowspan="1" colspan="1">MI</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Narne et al. <xref ref-type="bibr" rid="pone.0113363-Narne1">[90]</xref></td>
<td align="left" rowspan="1" colspan="1">2013</td>
<td align="left" rowspan="1" colspan="1">India</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp, 4b/a, T786-C</td>
<td align="left" rowspan="1" colspan="1">0.21/0.16</td>
<td align="left" rowspan="1" colspan="1">0.19/0.19</td>
<td align="left" rowspan="1" colspan="1">0.29/0.18</td>
<td align="left" rowspan="1" colspan="1">281 for each</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td colspan="3" align="left" rowspan="1"><bold>AFRICAN ANCESTRY GROUP</bold></td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Hooper et al. <xref ref-type="bibr" rid="pone.0113363-Hooper1">[98]</xref></td>
<td align="left" rowspan="1" colspan="1">1999</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">4b/a</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.36/0.26</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">295</td>
<td align="left" rowspan="1" colspan="1">MI</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Rao et al.(2) <xref ref-type="bibr" rid="pone.0113363-Rao1">[104]</xref></td>
<td align="left" rowspan="1" colspan="1">2005</td>
<td align="left" rowspan="1" colspan="1">USA</td>
<td align="left" rowspan="1" colspan="1">4b/a</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">0.36/0.26</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">43</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Rios et al.(2) <xref ref-type="bibr" rid="pone.0113363-Rios2">[57]</xref></td>
<td align="left" rowspan="1" colspan="1">2007</td>
<td align="left" rowspan="1" colspan="1">Brazil</td>
<td align="left" rowspan="1" colspan="1">Glu298Asp, 4b/a, T786-C</td>
<td align="left" rowspan="1" colspan="1">0.27/0.22</td>
<td align="left" rowspan="1" colspan="1">0.21/0.20</td>
<td align="left" rowspan="1" colspan="1">0.32/0.22</td>
<td align="left" rowspan="1" colspan="1">268 for each</td>
<td align="left" rowspan="1" colspan="1">CAD</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt101"><label/><p>The studies were grouped according to predominant ancestry among which they were conducted.</p></fn><fn id="nt102"><label/><p>Abbreviations used- CAD: Coronary Artery Disease; MI: Myocardial Infarction; AMI: Acute Myocardial Infarction; ACS: Acute Coronary Syndrome; PCAD: Premature CAD; PMI: Premature MI; CVD: Cardiovascular Disease</p></fn></table-wrap-foot></table-wrap><sec id="s3a">
<title>Meta-analysis for <italic>NOS3</italic> Glu298Asp polymorphism</title>
<sec id="s3a1">
<title>Pooled analysis</title>
<p>A total of 60 case control studies <xref ref-type="bibr" rid="pone.0113363-Gardemann1">[2]</xref>, <xref ref-type="bibr" rid="pone.0113363-Hingorani1">[3]</xref>, <xref ref-type="bibr" rid="pone.0113363-Colombo2">[5]</xref>, <xref ref-type="bibr" rid="pone.0113363-Shimasaki1">[10]</xref>, <xref ref-type="bibr" rid="pone.0113363-Hibi1">[11]</xref>, <xref ref-type="bibr" rid="pone.0113363-Angeline1">[13]</xref>–<xref ref-type="bibr" rid="pone.0113363-Salimi1">[16]</xref>, <xref ref-type="bibr" rid="pone.0113363-Cai1">[18]</xref>, <xref ref-type="bibr" rid="pone.0113363-Schmoelzer1">[20]</xref>–<xref ref-type="bibr" rid="pone.0113363-Alp1">[23]</xref>, <xref ref-type="bibr" rid="pone.0113363-Rios1">[28]</xref>, <xref ref-type="bibr" rid="pone.0113363-Ragia1">[32]</xref>, <xref ref-type="bibr" rid="pone.0113363-Granath1">[37]</xref>–<xref ref-type="bibr" rid="pone.0113363-Jaramillo2">[39]</xref>, <xref ref-type="bibr" rid="pone.0113363-Pulkkinen1">[53]</xref>–<xref ref-type="bibr" rid="pone.0113363-Narne1">[90]</xref> investigating the association between Glu298Asp polymorphism and CAD, with a total of 15,957 CAD patients and 14,075 normal controls were included in the pooled analysis (All ancestries combined). (<xref ref-type="table" rid="pone-0113363-t001"><bold>Tables 1</bold></xref><bold> and </bold><xref ref-type="table" rid="pone-0113363-t002"><bold>2</bold></xref>) This analysis, using three different genetic models showed moderate to high heterogeneity (<italic>I<sup>2</sup></italic> range = 58–72% and P<sub>Q</sub>&lt;0.00001 for all comparisons). (<xref ref-type="table" rid="pone-0113363-t002"><bold>Table 2</bold></xref>) All three genetic models for Glu298Asp also showed significant association with CAD (OR range = 1.28–1.52, Z value range = 5.14–6.33 and P&lt;0.00001 for all comparisons). (<xref ref-type="table" rid="pone-0113363-t003"><bold>Table 3</bold></xref><bold> and </bold><xref ref-type="fig" rid="pone-0113363-g002"><bold>Figures 2</bold></xref><bold>, <xref ref-type="supplementary-material" rid="pone.0113363.s001">S1</xref> and <xref ref-type="supplementary-material" rid="pone.0113363.s002">S2</xref></bold>)</p>
<fig id="pone-0113363-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0113363.g002</object-id><label>Figure 2</label><caption>
<title>Forest plot depicting results after analyses for the allelic model <italic>(Allele T vs. G)</italic> of <italic>NOS3</italic> Glu298Asp polymorphism.</title>
<p>Effect size estimates for all ancestral groups in this plot were obtained using random effects for analysis. Effect size using fixed effects was recalculated for Asian-Indian group which showed homogenous distribution among its included studies. Recalculated effect size estimate for Asian-Indians was, OR, 95%CI = 1.23, 1.05–1.44; Z = 2.59; P = 0.01.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0113363.g002" position="float" xlink:type="simple"/></fig><table-wrap id="pone-0113363-t002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0113363.t002</object-id><label>Table 2</label><caption>
<title>Basic characteristics of the studied groups classified according to predominant ancestries.</title>
</caption><alternatives><graphic id="pone-0113363-t002-2" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0113363.t002" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">
</td>
<td colspan="3" align="left" rowspan="1">Heterogeneity (<italic>I<sup>2</sup></italic>; P<sub>Q</sub>)</td>
<td align="left" rowspan="1" colspan="1">Number of Studies</td>
<td align="left" rowspan="1" colspan="1">Cases (n)/Controls (n)</td>
<td align="left" rowspan="1" colspan="1">Total sample</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
</td>
<td align="left" rowspan="1" colspan="1"><italic>Dominant genetic model</italic><xref ref-type="table-fn" rid="nt104">*</xref></td>
<td align="left" rowspan="1" colspan="1"><italic>Recessive genetic model</italic><xref ref-type="table-fn" rid="nt105">**</xref></td>
<td align="left" rowspan="1" colspan="1"><italic>Allelic genetic model</italic><xref ref-type="table-fn" rid="nt106">***</xref></td>
<td align="left" rowspan="1" colspan="1">
</td>
<td align="left" rowspan="1" colspan="1">
</td>
<td align="left" rowspan="1" colspan="1">
</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Glu298Asp polymorphism</bold></td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">All ancestries combined</td>
<td align="left" rowspan="1" colspan="1">65%; &lt;0.00001</td>
<td align="left" rowspan="1" colspan="1">58%; &lt;0.00001</td>
<td align="left" rowspan="1" colspan="1">72%; &lt;0.00001</td>
<td align="left" rowspan="1" colspan="1">60</td>
<td align="left" rowspan="1" colspan="1">15,957/14,075</td>
<td align="left" rowspan="1" colspan="1">30,032</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">European ancestry group</td>
<td align="left" rowspan="1" colspan="1">52%; 0.0008</td>
<td align="left" rowspan="1" colspan="1">63%; &lt;0.00001</td>
<td align="left" rowspan="1" colspan="1">69%; &lt;0.00001</td>
<td align="left" rowspan="1" colspan="1">27</td>
<td align="left" rowspan="1" colspan="1">10,738/7,748</td>
<td align="left" rowspan="1" colspan="1">18,486</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Middle Eastern ancestry group</td>
<td align="left" rowspan="1" colspan="1">64%; 0.0005</td>
<td align="left" rowspan="1" colspan="1">65%; 0.0005</td>
<td align="left" rowspan="1" colspan="1">77%; &lt;0.00001</td>
<td align="left" rowspan="1" colspan="1">14</td>
<td align="left" rowspan="1" colspan="1">2,303/1,752</td>
<td align="left" rowspan="1" colspan="1">4,055</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Asian ancestry group</td>
<td align="left" rowspan="1" colspan="1">78%; &lt;0.00001</td>
<td align="left" rowspan="1" colspan="1">33%; 0.16</td>
<td align="left" rowspan="1" colspan="1">68%; 0.0008</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">1,649/3,159</td>
<td align="left" rowspan="1" colspan="1">4,808</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Asian-Indian ancestry group</td>
<td align="left" rowspan="1" colspan="1">18%; 0.28</td>
<td align="left" rowspan="1" colspan="1">23%; 0.26</td>
<td align="left" rowspan="1" colspan="1">21%; 0.27</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">1,120/1,295</td>
<td align="left" rowspan="1" colspan="1">2,415</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">African ancestry group</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">147/121</td>
<td align="left" rowspan="1" colspan="1">268</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>T786-C polymorphism</bold></td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">All ancestries combined</td>
<td align="left" rowspan="1" colspan="1">66%; &lt;0.00001</td>
<td align="left" rowspan="1" colspan="1">35%; 0.03</td>
<td align="left" rowspan="1" colspan="1">69%; &lt;0.00001</td>
<td align="left" rowspan="1" colspan="1">29</td>
<td align="left" rowspan="1" colspan="1">7,043/10,409</td>
<td align="left" rowspan="1" colspan="1">17,452</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">European ancestry group</td>
<td align="left" rowspan="1" colspan="1">71%; &lt;0.00001</td>
<td align="left" rowspan="1" colspan="1">38%; 0.07</td>
<td align="left" rowspan="1" colspan="1">72%; &lt;0.00001</td>
<td align="left" rowspan="1" colspan="1">15</td>
<td align="left" rowspan="1" colspan="1">3,977/3,234</td>
<td align="left" rowspan="1" colspan="1">7,211</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Middle Eastern ancestry group</td>
<td align="left" rowspan="1" colspan="1">50%; 0.09</td>
<td align="left" rowspan="1" colspan="1">68%; 0.01</td>
<td align="left" rowspan="1" colspan="1">70%; 0.009</td>
<td align="left" rowspan="1" colspan="1">5</td>
<td align="left" rowspan="1" colspan="1">879/691</td>
<td align="left" rowspan="1" colspan="1">1,570</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Asian ancestry group</td>
<td align="left" rowspan="1" colspan="1">67%; 0.009</td>
<td align="left" rowspan="1" colspan="1">0%; 0.69</td>
<td align="left" rowspan="1" colspan="1">68%; 0.009</td>
<td align="left" rowspan="1" colspan="1">6</td>
<td align="left" rowspan="1" colspan="1">1,593/5,642</td>
<td align="left" rowspan="1" colspan="1">7,235</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Asian-Indian ancestry group</td>
<td align="left" rowspan="1" colspan="1">50%; 0.16</td>
<td align="left" rowspan="1" colspan="1">70%; 0.07</td>
<td align="left" rowspan="1" colspan="1">69%; 0.07</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">447/721</td>
<td align="left" rowspan="1" colspan="1">1,168</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">African ancestry group</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">-</td>
<td align="left" rowspan="1" colspan="1">1</td>
<td align="left" rowspan="1" colspan="1">147/121</td>
<td align="left" rowspan="1" colspan="1">268</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>4b/a polymorphism</bold></td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">All ancestries combined</td>
<td align="left" rowspan="1" colspan="1">60%; &lt;0.00001</td>
<td align="left" rowspan="1" colspan="1">17%; 0.17</td>
<td align="left" rowspan="1" colspan="1">61%; &lt;0.00001</td>
<td align="left" rowspan="1" colspan="1">43</td>
<td align="left" rowspan="1" colspan="1">12,477/9,274</td>
<td align="left" rowspan="1" colspan="1">21,751</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">European ancestry group</td>
<td align="left" rowspan="1" colspan="1">51%; 0.005</td>
<td align="left" rowspan="1" colspan="1">0%; 0.72</td>
<td align="left" rowspan="1" colspan="1">47%; 0.01</td>
<td align="left" rowspan="1" colspan="1">20</td>
<td align="left" rowspan="1" colspan="1">8,779/5,373</td>
<td align="left" rowspan="1" colspan="1">14,152</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Middle Eastern ancestry group</td>
<td align="left" rowspan="1" colspan="1">0%; 0.83</td>
<td align="left" rowspan="1" colspan="1">0%; 0.66</td>
<td align="left" rowspan="1" colspan="1">0%; 0.80</td>
<td align="left" rowspan="1" colspan="1">8</td>
<td align="left" rowspan="1" colspan="1">1,356/1,314</td>
<td align="left" rowspan="1" colspan="1">2,670</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Asian ancestry group</td>
<td align="left" rowspan="1" colspan="1">28%; 0.18</td>
<td align="left" rowspan="1" colspan="1">0%; 0.72</td>
<td align="left" rowspan="1" colspan="1">0%; 0.50</td>
<td align="left" rowspan="1" colspan="1">10</td>
<td align="left" rowspan="1" colspan="1">1,797/2,039</td>
<td align="left" rowspan="1" colspan="1">3,836</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Asian-Indian ancestry group</td>
<td align="left" rowspan="1" colspan="1">87%; 0.005</td>
<td align="left" rowspan="1" colspan="1">0%; 0.65</td>
<td align="left" rowspan="1" colspan="1">87%; 0.005</td>
<td align="left" rowspan="1" colspan="1">2</td>
<td align="left" rowspan="1" colspan="1">266/221</td>
<td align="left" rowspan="1" colspan="1">487</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">African ancestry group</td>
<td align="left" rowspan="1" colspan="1">33%; 0.22</td>
<td align="left" rowspan="1" colspan="1">0%; 0.58</td>
<td align="left" rowspan="1" colspan="1">0%; 0.37</td>
<td align="left" rowspan="1" colspan="1">3</td>
<td align="left" rowspan="1" colspan="1">279/327</td>
<td align="left" rowspan="1" colspan="1">606</td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt103"><label/><p>Abbreviations: P<sub>Q</sub>: Cochran's Q statistics; <italic>I<sup>2</sup></italic>: Higgin's <italic>I<sup>2</sup></italic> statistics.</p></fn><fn id="nt104"><label/><p>*Dominant genetic model for Glu298Asp: <italic>TT+GT vs. GG;</italic> for T786-C: <italic>CC+CT vs. TT;</italic> for 4b/a: <italic>4a4a+4a4b vs. 4b4b.</italic></p></fn><fn id="nt105"><label/><p>**Recessive genetic model for Glu298Asp: <italic>TT vs. GG+GT;</italic> for T786-C: <italic>CC vs. TT+CT;</italic> for 4b/a: <italic>4a4a vs. 4a4b+4b4b.</italic></p></fn><fn id="nt106"><label/><p>***Allelic genetic model for Glu298Asp: <italic>Allele T vs. G;</italic> for T786-C: <italic>Allele C vs. T;</italic> for 4b/a: <italic>Allele 4a vs. 4b.</italic></p></fn><fn id="nt107"><label/><p>Notes: Heterogeneity was tested among groups of studies using Higgin's <italic>I<sup>2</sup></italic> statistics and Cochran's Q statistics (P<sub>Q</sub>). Group showing <italic>I<sup>2</sup></italic>&gt;50% and P<sub>Q</sub>&lt;0.01 were considered heterogeneous, others were considered homogenous.</p></fn></table-wrap-foot></table-wrap><table-wrap id="pone-0113363-t003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0113363.t003</object-id><label>Table 3</label><caption>
<title>Meta-analysis results for <italic>NOS3</italic> gene polymorphisms.</title>
</caption><alternatives><graphic id="pone-0113363-t003-3" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0113363.t003" xlink:type="simple"/>
<table><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup>
<thead>
<tr>
<td align="left" rowspan="1" colspan="1">
</td>
<td colspan="2" align="left" rowspan="1"><italic>Dominant genetic model</italic><xref ref-type="table-fn" rid="nt109">*</xref></td>
<td colspan="2" align="left" rowspan="1"><italic>Recessive genetic model</italic><xref ref-type="table-fn" rid="nt110">**</xref></td>
<td colspan="2" align="left" rowspan="1"><italic>Allelic genetic model</italic><xref ref-type="table-fn" rid="nt111">***</xref></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">
</td>
<td align="left" rowspan="1" colspan="1">OR, 95% CI</td>
<td align="left" rowspan="1" colspan="1">Z; P value</td>
<td align="left" rowspan="1" colspan="1">OR, 95% CI</td>
<td align="left" rowspan="1" colspan="1">Z; P value</td>
<td align="left" rowspan="1" colspan="1">OR, 95% CI</td>
<td align="left" rowspan="1" colspan="1">Z; P value</td>
</tr>
</thead>
<tbody>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>Glu298Asp polymorphism</bold></td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">All ancestries combined</td>
<td align="left" rowspan="1" colspan="1">1.28, 1.17-1.40</td>
<td align="left" rowspan="1" colspan="1">5.34; &lt;0.00001</td>
<td align="left" rowspan="1" colspan="1">1.52, 1.30-1.79</td>
<td align="left" rowspan="1" colspan="1">5.14; &lt;0.00001</td>
<td align="left" rowspan="1" colspan="1">1.29, 1.19-1.40</td>
<td align="left" rowspan="1" colspan="1">6.33; &lt;0.00001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">European ancestry group</td>
<td align="left" rowspan="1" colspan="1">1.11, 1.01–1.22</td>
<td align="left" rowspan="1" colspan="1">2.10; 0.04</td>
<td align="left" rowspan="1" colspan="1">1.36, 1.14–1.63</td>
<td align="left" rowspan="1" colspan="1">3.37; 0.0007</td>
<td align="left" rowspan="1" colspan="1">1.15, 1.05–1.26</td>
<td align="left" rowspan="1" colspan="1">3.08; 0.002</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Middle Eastern ancestry group</td>
<td align="left" rowspan="1" colspan="1">1.55, 1.25–1.93</td>
<td align="left" rowspan="1" colspan="1">3.94; &lt;0.0001</td>
<td align="left" rowspan="1" colspan="1">1.87, 1.23–2.85</td>
<td align="left" rowspan="1" colspan="1">2.92; 0.004</td>
<td align="left" rowspan="1" colspan="1">1.54, 1.24–1.91</td>
<td align="left" rowspan="1" colspan="1">3.94; &lt;0.0001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Asian ancestry group</td>
<td align="left" rowspan="1" colspan="1">1.60, 1.12–2.29</td>
<td align="left" rowspan="1" colspan="1">2.56; 0.01</td>
<td align="left" rowspan="1" colspan="1">2.22, 1.21–4.08<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">2.57; 0.01<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">1.51, 1.15–1.98</td>
<td align="left" rowspan="1" colspan="1">3.00; 0.003</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Asian-Indian ancestry group</td>
<td align="left" rowspan="1" colspan="1">1.21, 1.01–1.45<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">2.07; 0.04<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">1.85, 1.12–3.04<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">2.42; 0.02<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">1.23, 1.05–1.44<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">2.59; 0.01<sup>F</sup></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">African ancestry group</td>
<td align="left" rowspan="1" colspan="1">1.22, 0.75–1.99</td>
<td align="left" rowspan="1" colspan="1">0.81; 0.42</td>
<td align="left" rowspan="1" colspan="1">2.84, 0.90–8.94</td>
<td align="left" rowspan="1" colspan="1">1.78; 0.07</td>
<td align="left" rowspan="1" colspan="1">1.32, 0.89–1.97</td>
<td align="left" rowspan="1" colspan="1">1.39; 0.17</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>T786-C polymorphism</bold></td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">All ancestries combined</td>
<td align="left" rowspan="1" colspan="1">1.42, 1.25–1.62</td>
<td align="left" rowspan="1" colspan="1">5.24; &lt;0.00001</td>
<td align="left" rowspan="1" colspan="1">1.36, 1.20–1.53<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">4.97; &lt;0.00001<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">1.34, 1.20–1.49</td>
<td align="left" rowspan="1" colspan="1">5.32; &lt;0.00001</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">European ancestry group</td>
<td align="left" rowspan="1" colspan="1">1.25, 1.02–1.52</td>
<td align="left" rowspan="1" colspan="1">2.19; 0.03</td>
<td align="left" rowspan="1" colspan="1">1.32, 1.15–1.52<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">3.96; &lt;0.0001<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">1.21, 1.05–1.40</td>
<td align="left" rowspan="1" colspan="1">2.56; 0.01</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Middle Eastern ancestry group</td>
<td align="left" rowspan="1" colspan="1">1.59, 1.16–2.18</td>
<td align="left" rowspan="1" colspan="1">2.91; 0.004</td>
<td align="left" rowspan="1" colspan="1">1.35, 0.69–2.65</td>
<td align="left" rowspan="1" colspan="1">0.87; 0.38</td>
<td align="left" rowspan="1" colspan="1">1.43, 1.04–1.97</td>
<td align="left" rowspan="1" colspan="1">2.20; 0.03</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Asian ancestry group</td>
<td align="left" rowspan="1" colspan="1">1.67, 1.26–2.23</td>
<td align="left" rowspan="1" colspan="1">3.51; 0.0004</td>
<td align="left" rowspan="1" colspan="1">1.90, 1.15–3.14<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">2.50; 0.01<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">1.61, 1.24–2.10</td>
<td align="left" rowspan="1" colspan="1">3.56; 0.0004</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Asian-Indian ancestry group</td>
<td align="left" rowspan="1" colspan="1">1.53, 1.04–2.26</td>
<td align="left" rowspan="1" colspan="1">2.16; 0.03</td>
<td align="left" rowspan="1" colspan="1">1.73, 0.38–7.95</td>
<td align="left" rowspan="1" colspan="1">0.71; 0.48</td>
<td align="left" rowspan="1" colspan="1">1.44, 0.95–2.18</td>
<td align="left" rowspan="1" colspan="1">1.71; 0.09</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">African ancestry group</td>
<td align="left" rowspan="1" colspan="1">1.91, 1.17–3.12</td>
<td align="left" rowspan="1" colspan="1">2.58; 0.010</td>
<td align="left" rowspan="1" colspan="1">1.85, 0.77–4.44</td>
<td align="left" rowspan="1" colspan="1">1.37; 0.17</td>
<td align="left" rowspan="1" colspan="1">1.70, 1.15–2.52</td>
<td align="left" rowspan="1" colspan="1">2.67; 0.008</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1"><bold>4b/a polymorphism</bold></td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
<td align="left" rowspan="1" colspan="1"> </td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">All ancestries combined</td>
<td align="left" rowspan="1" colspan="1">1.19, 1.07–1.32</td>
<td align="left" rowspan="1" colspan="1">3.11; 0.002</td>
<td align="left" rowspan="1" colspan="1">1.41, 1.19–1.67<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">3.99; &lt;0.0001<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">1.20, 1.09–1.32</td>
<td align="left" rowspan="1" colspan="1">3.77; 0.0002</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">European ancestry group</td>
<td align="left" rowspan="1" colspan="1">1.00, 0.89–1.13</td>
<td align="left" rowspan="1" colspan="1">0.06; 0.95</td>
<td align="left" rowspan="1" colspan="1">1.03, 0.83–1.26<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">0.24; 0.81<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">0.99, 0.93–1.06<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">0.19; 0.85<sup>F</sup></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Middle Eastern ancestry group</td>
<td align="left" rowspan="1" colspan="1">1.73, 1.46–2.05<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">6.28; &lt;0.00001<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">3.02, 1.90–4.81<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">4.65; &lt;0.00001<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">1.71, 1.47–1.98<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">7.09; &lt;0.00001<sup>F</sup></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Asian ancestry group</td>
<td align="left" rowspan="1" colspan="1">1.22, 1.04–1.42<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">2.45; 0.01<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">2.48, 1.38–4.47<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">3.03; 0.002<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">1.25, 1.08–1.44<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">3.06; 0.002<sup>F</sup></td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">Asian-Indian ancestry group</td>
<td align="left" rowspan="1" colspan="1">1.57, 0.53–4.64</td>
<td align="left" rowspan="1" colspan="1">0.82; 0.41</td>
<td align="left" rowspan="1" colspan="1">2.63, 1.02–6.82<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">1.99; 0.05<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">1.56, 0.62–3.94</td>
<td align="left" rowspan="1" colspan="1">0.94; 0.35</td>
</tr>
<tr>
<td align="left" rowspan="1" colspan="1">African ancestry group</td>
<td align="left" rowspan="1" colspan="1">1.37, 0.99–1.90<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">1.87; 0.06<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">2.02, 1.04–3.91<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">2.07; 0.04<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">1.37, 1.05–1.78<sup>F</sup></td>
<td align="left" rowspan="1" colspan="1">2.34; 0.02<sup>F</sup></td>
</tr>
</tbody>
</table>
</alternatives><table-wrap-foot><fn id="nt108"><label/><p>Abbreviations: OR, 95% CI: Odds Ratio with its 95% Confidence Interval; <bold><sup>F</sup></bold>: Results derived using Fixed effects for analysis. Random effects were used for all other calculations.</p></fn><fn id="nt109"><label/><p>*Dominant genetic model for Glu298Asp: <italic>TT+GT vs. GG;</italic> for T786-C: <italic>CC+CT vs. TT;</italic> for 4b/a: <italic>4a4a+4a4b vs. 4b4b.</italic></p></fn><fn id="nt110"><label/><p>**Recessive genetic model for Glu298Asp: <italic>TT vs. GG+GT;</italic> for T786-C: <italic>CC vs. TT+CT;</italic> for 4b/a: <italic>4a4a vs. 4a4b+4b4b.</italic></p></fn><fn id="nt111"><label/><p>***Allelic genetic model for Glu298Asp: <italic>Allele T vs. G;</italic> for T786-C: <italic>Allele C vs. T;</italic> for 4b/a: <italic>Allele 4a vs. 4b.</italic></p></fn></table-wrap-foot></table-wrap></sec><sec id="s3a2">
<title>Subgroup analysis</title>
<p>Among subgroups for Glu298Asp, 17 studies belonged to the European, <xref ref-type="bibr" rid="pone.0113363-Gardemann1">[2]</xref>, <xref ref-type="bibr" rid="pone.0113363-Hingorani1">[3]</xref>, <xref ref-type="bibr" rid="pone.0113363-Colombo2">[5]</xref>, <xref ref-type="bibr" rid="pone.0113363-Dafni1">[15]</xref>, <xref ref-type="bibr" rid="pone.0113363-Cai1">[18]</xref>, <xref ref-type="bibr" rid="pone.0113363-Schmoelzer1">[20]</xref>, <xref ref-type="bibr" rid="pone.0113363-Jaramillo1">[21]</xref>, <xref ref-type="bibr" rid="pone.0113363-Rios1">[28]</xref>, <xref ref-type="bibr" rid="pone.0113363-Ragia1">[32]</xref>, <xref ref-type="bibr" rid="pone.0113363-Granath1">[37]</xref>–<xref ref-type="bibr" rid="pone.0113363-Jaramillo2">[39]</xref>, <xref ref-type="bibr" rid="pone.0113363-Pulkkinen1">[53]</xref>–<xref ref-type="bibr" rid="pone.0113363-Zigra1">[65]</xref> 14 to the Middle Eastern, <xref ref-type="bibr" rid="pone.0113363-BorKucukatay1">[14]</xref>, <xref ref-type="bibr" rid="pone.0113363-Salimi1">[16]</xref>, <xref ref-type="bibr" rid="pone.0113363-Alp1">[23]</xref>, <xref ref-type="bibr" rid="pone.0113363-Aras1">[66]</xref>–<xref ref-type="bibr" rid="pone.0113363-Kallel1">[76]</xref> 10 to the Asian, <xref ref-type="bibr" rid="pone.0113363-Shimasaki1">[10]</xref>, <xref ref-type="bibr" rid="pone.0113363-Hibi1">[11]</xref>, <xref ref-type="bibr" rid="pone.0113363-Kim1">[22]</xref>, <xref ref-type="bibr" rid="pone.0113363-Yoon1">[77]</xref>–<xref ref-type="bibr" rid="pone.0113363-Min1">[83]</xref> 8 to the Asian-Indian <xref ref-type="bibr" rid="pone.0113363-Angeline1">[13]</xref>, <xref ref-type="bibr" rid="pone.0113363-Mathew1">[84]</xref>–<xref ref-type="bibr" rid="pone.0113363-Narne1">[90]</xref> and 1 to the African <xref ref-type="bibr" rid="pone.0113363-Rios2">[57]</xref> group. (<xref ref-type="table" rid="pone-0113363-t001"><bold>Tables 1</bold></xref><bold> and </bold><xref ref-type="table" rid="pone-0113363-t002"><bold>2</bold></xref>) The Asian-Indian subgroup in all its genetic models showed low heterogeneity (<italic>I<sup>2</sup></italic> range = 18–23% and P<sub>Q</sub> range = 0.26–0.28). All other ancestral groups (apart from African which had only 1 study) showed moderate to high heterogeneity (<italic>I<sup>2</sup></italic> range = 33–78% and P<sub>Q</sub> range = 0.16 to &lt;0.00001). (<xref ref-type="table" rid="pone-0113363-t002"><bold>Table 2</bold></xref>) Appropriate effects were thus used for further analysis. Four out of 5 ancestral groups (except Africans) showed significant association with CAD in all three genetic models. The Middle Eastern group showed highest levels of association amongst the studied groups (Z value range = 2.92–3.94 and P≤0.004 for all comparisons), followed by European group (Z value range = 2.10–3.37 and P≤0.04 for all comparisons). (<xref ref-type="table" rid="pone-0113363-t003"><bold>Table 3</bold></xref><bold> and </bold><xref ref-type="fig" rid="pone-0113363-g002"><bold>Figures 2</bold></xref><bold>, <xref ref-type="supplementary-material" rid="pone.0113363.s001">S1</xref> and <xref ref-type="supplementary-material" rid="pone.0113363.s002">S2</xref></bold>)</p>
</sec></sec><sec id="s3b">
<title>Meta-analysis for <italic>NOS3</italic> T786-C polymorphism</title>
<sec id="s3b1">
<title>Pooled analysis</title>
<p>Twenty nine case-control studies <xref ref-type="bibr" rid="pone.0113363-Colombo2">[5]</xref>, <xref ref-type="bibr" rid="pone.0113363-Salimi2">[17]</xref>, <xref ref-type="bibr" rid="pone.0113363-Kim1">[22]</xref>, <xref ref-type="bibr" rid="pone.0113363-Alp1">[23]</xref>, <xref ref-type="bibr" rid="pone.0113363-Alvarez1">[27]</xref>, <xref ref-type="bibr" rid="pone.0113363-Rios1">[28]</xref>, <xref ref-type="bibr" rid="pone.0113363-Nakayama2">[31]</xref>, <xref ref-type="bibr" rid="pone.0113363-Ragia1">[32]</xref>, <xref ref-type="bibr" rid="pone.0113363-Granath1">[37]</xref>, <xref ref-type="bibr" rid="pone.0113363-Jaramillo2">[39]</xref>, <xref ref-type="bibr" rid="pone.0113363-Agema1">[54]</xref>, <xref ref-type="bibr" rid="pone.0113363-Fatini1">[55]</xref>, <xref ref-type="bibr" rid="pone.0113363-Rios2">[57]</xref>, <xref ref-type="bibr" rid="pone.0113363-Sampaio1">[58]</xref>, <xref ref-type="bibr" rid="pone.0113363-Gluba1">[62]</xref>, <xref ref-type="bibr" rid="pone.0113363-daCostaEscobarPiccoli1">[64]</xref>, <xref ref-type="bibr" rid="pone.0113363-Zigra1">[65]</xref>, <xref ref-type="bibr" rid="pone.0113363-Kallel1">[76]</xref>, <xref ref-type="bibr" rid="pone.0113363-Jo1">[79]</xref>, <xref ref-type="bibr" rid="pone.0113363-Bae1">[82]</xref>, <xref ref-type="bibr" rid="pone.0113363-ArunKumar1">[89]</xref>–<xref ref-type="bibr" rid="pone.0113363-Han1">[97]</xref> with 7,043 CAD patients and 10,409 controls, investigating the association between T786-C polymorphism and CAD were included in the pooled analysis.(<xref ref-type="table" rid="pone-0113363-t001"><bold>Tables 1</bold></xref><bold> and </bold><xref ref-type="table" rid="pone-0113363-t002"><bold>2</bold></xref>) Moderate heterogeneity was seen across all genetic models (<italic>I<sup>2</sup></italic> range = 35–69%, P<sub>Q</sub> range = 0.03 to &lt;0.00001). (<xref ref-type="table" rid="pone-0113363-t002"><bold>Table 2</bold></xref>) All genetic models also showed significantly associated with CAD showing ORs in the range of 1.34–1.42, Z value ranging from 4.97–5.32 and P values of &lt;0.00001 (for all comparisons). (<xref ref-type="table" rid="pone-0113363-t003"><bold>Table 3</bold></xref><bold> and </bold><xref ref-type="fig" rid="pone-0113363-g003"><bold>Figures 3</bold></xref><bold>, <xref ref-type="supplementary-material" rid="pone.0113363.s003">S3</xref> and <xref ref-type="supplementary-material" rid="pone.0113363.s004">S4</xref></bold>)</p>
<fig id="pone-0113363-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0113363.g003</object-id><label>Figure 3</label><caption>
<title>Forest plot depicting results after analyses for the allelic model <italic>(Allele C vs. T)</italic> of <italic>NOS3</italic> T786-C polymorphism.</title>
<p>Effect size estimates for all ancestral groups in this plot were obtained using random effects for analysis.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0113363.g003" position="float" xlink:type="simple"/></fig></sec><sec id="s3b2">
<title>Subgroup analysis</title>
<p>Among the ancestral subgroups, 15 studies constituted the European group, <xref ref-type="bibr" rid="pone.0113363-Colombo2">[5]</xref>, <xref ref-type="bibr" rid="pone.0113363-Alvarez1">[27]</xref>, <xref ref-type="bibr" rid="pone.0113363-Rios1">[28]</xref>, <xref ref-type="bibr" rid="pone.0113363-Ragia1">[32]</xref>, <xref ref-type="bibr" rid="pone.0113363-Granath1">[37]</xref>, <xref ref-type="bibr" rid="pone.0113363-Jaramillo2">[39]</xref>, <xref ref-type="bibr" rid="pone.0113363-Agema1">[54]</xref>, <xref ref-type="bibr" rid="pone.0113363-Fatini1">[55]</xref>, <xref ref-type="bibr" rid="pone.0113363-Sampaio1">[58]</xref>, <xref ref-type="bibr" rid="pone.0113363-Gluba1">[62]</xref>, <xref ref-type="bibr" rid="pone.0113363-daCostaEscobarPiccoli1">[64]</xref>, <xref ref-type="bibr" rid="pone.0113363-Zigra1">[65]</xref>, <xref ref-type="bibr" rid="pone.0113363-Dosenko1">[91]</xref>–<xref ref-type="bibr" rid="pone.0113363-Meluzin1">[93]</xref> while 5,6,2 and 1 study respectively constituted Middle Eastern, <xref ref-type="bibr" rid="pone.0113363-Salimi2">[17]</xref>, <xref ref-type="bibr" rid="pone.0113363-Alp1">[23]</xref>, <xref ref-type="bibr" rid="pone.0113363-Kallel1">[76]</xref>, <xref ref-type="bibr" rid="pone.0113363-Tangurek1">[94]</xref>, <xref ref-type="bibr" rid="pone.0113363-Ciftci1">[95]</xref> Asian, <xref ref-type="bibr" rid="pone.0113363-Kim1">[22]</xref>, <xref ref-type="bibr" rid="pone.0113363-Nakayama2">[31]</xref>, <xref ref-type="bibr" rid="pone.0113363-Jo1">[79]</xref>, <xref ref-type="bibr" rid="pone.0113363-Bae1">[82]</xref>, <xref ref-type="bibr" rid="pone.0113363-Takagi1">[96]</xref>, <xref ref-type="bibr" rid="pone.0113363-Han1">[97]</xref> Asian-Indian <xref ref-type="bibr" rid="pone.0113363-ArunKumar1">[89]</xref>, <xref ref-type="bibr" rid="pone.0113363-Narne1">[90]</xref> and African <xref ref-type="bibr" rid="pone.0113363-Rios2">[57]</xref> group. (<xref ref-type="table" rid="pone-0113363-t001"><bold>Tables 1</bold></xref><bold> and </bold><xref ref-type="table" rid="pone-0113363-t002"><bold>2</bold></xref>) Moderate to high degree of heterogeneity was seen in almost all ancestral groups (except Africans, which had only 1 study), and in amongst almost all comparisons, barring the recessive model amongst the Asians which was rather homogenous (<italic>I<sup>2</sup></italic> range = 50–72%, P<sub>Q</sub> range = 0.16 to &lt;0.00001). (<xref ref-type="table" rid="pone-0113363-t002"><bold>Table 2</bold></xref>) All ancestral subgroups showed significant association in dominant genetic model, similarly all (except Asian-Indians) showed significant association in the allelic model. On the other hand, only Europeans and Asians showed significant association in recessive model. If we disregard the Africans which had only 1 study in its subgroup, Asians showed the highest degree of association consistently in all three models (OR range = 1.61–1.90, Z value range = 2.50–3.56 and P value range = 0.01–0.0004), followed by the Europeans (OR range = 1.21–1.32, Z value range = 2.19–3.96 and P value range = 0.03 to &lt;0.0001). (<xref ref-type="table" rid="pone-0113363-t003"><bold>Table 3</bold></xref><bold> and </bold><xref ref-type="fig" rid="pone-0113363-g003"><bold>Figures 3</bold></xref><bold> <xref ref-type="supplementary-material" rid="pone.0113363.s003">S3</xref> and <xref ref-type="supplementary-material" rid="pone.0113363.s004">S4</xref></bold>)</p>
</sec></sec><sec id="s3c">
<title>Meta-analysis <italic>4b/a (27bp VNTR)</italic> polymorphism</title>
<sec id="s3c1">
<title>Pooled analysis</title>
<p>Forty three case-control studies, <xref ref-type="bibr" rid="pone.0113363-Gardemann1">[2]</xref>, <xref ref-type="bibr" rid="pone.0113363-Hibi1">[11]</xref>, <xref ref-type="bibr" rid="pone.0113363-Kim1">[22]</xref>, <xref ref-type="bibr" rid="pone.0113363-Alvarez1">[27]</xref>, <xref ref-type="bibr" rid="pone.0113363-Wang1">[33]</xref>–<xref ref-type="bibr" rid="pone.0113363-Granath1">[37]</xref>, <xref ref-type="bibr" rid="pone.0113363-Jaramillo2">[39]</xref>, <xref ref-type="bibr" rid="pone.0113363-Agema1">[54]</xref>, <xref ref-type="bibr" rid="pone.0113363-Fatini1">[55]</xref>, <xref ref-type="bibr" rid="pone.0113363-Rios2">[57]</xref>, <xref ref-type="bibr" rid="pone.0113363-Sampaio1">[58]</xref>, <xref ref-type="bibr" rid="pone.0113363-Vasilakou1">[61]</xref>, <xref ref-type="bibr" rid="pone.0113363-daCostaEscobarPiccoli1">[64]</xref>, <xref ref-type="bibr" rid="pone.0113363-Kallel1">[76]</xref>, <xref ref-type="bibr" rid="pone.0113363-Lin1">[80]</xref>, <xref ref-type="bibr" rid="pone.0113363-Bae1">[82]</xref>, <xref ref-type="bibr" rid="pone.0113363-Narne1">[90]</xref>, <xref ref-type="bibr" rid="pone.0113363-Dosenko1">[91]</xref>, <xref ref-type="bibr" rid="pone.0113363-Meluzin1">[93]</xref>, <xref ref-type="bibr" rid="pone.0113363-Hooper1">[98]</xref>–<xref ref-type="bibr" rid="pone.0113363-Gururajan1">[116]</xref> with 12,477 CAD patients and 9,274 controls analysing the association of 27bp b/a VNTR polymorphism and CAD were included in the pooled analysis. (<xref ref-type="table" rid="pone-0113363-t002"><bold>Table 2</bold></xref>) Low to moderate heterogeneity was seen among the three genetic models (<italic>I<sup>2</sup></italic> = 17–61%, P<sub>Q</sub> = 0.17 to &lt;0.00001). (<xref ref-type="table" rid="pone-0113363-t002"><bold>Table 2</bold></xref>) However, all three genetic models consistently showed significant association with CAD (OR range = 1.19–1.41, Z value range = 3.11–3.99, P≤0.002 for all comparisons). (<xref ref-type="table" rid="pone-0113363-t003"><bold>Table 3</bold></xref><bold> and </bold><xref ref-type="fig" rid="pone-0113363-g004"><bold>Figures 4</bold></xref><bold>, <xref ref-type="supplementary-material" rid="pone.0113363.s005">S5</xref> and <xref ref-type="supplementary-material" rid="pone.0113363.s006">S6</xref></bold>)</p>
<fig id="pone-0113363-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0113363.g004</object-id><label>Figure 4</label><caption>
<title>Forest plot depicting results after analyses for the allelic model <italic>(Allele 4a vs. 4b)</italic> of <italic>NOS3</italic> 4b/a VNTR polymorphism.</title>
<p>Effect size estimates for all ancestral groups in this plot were obtained using random effects for analysis. Effect sizes using fixed effects were recalculated for European, Middle Eastern, Asian and African groups which showed homogenous distribution among its included studies. Recalculated effect size estimates were, OR, 95%CI = 0.99, 0.93–1.06; Z = 0.19; P = 0.85 for Europeans; OR, 95%CI = 1.71, 1.47–1.98; Z = 7.09; P&lt;0.00001 for Middle Easterners; OR, 95%CI = 1.25, 1.08–1.44; Z = 3.06; P = 0.002 for Asians and OR, 95%CI = 1.37, 1.05–1.78; Z = 2.34; P = 0.02 for Africans.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0113363.g004" position="float" xlink:type="simple"/></fig></sec><sec id="s3c2">
<title>Subgroup analysis</title>
<p>A total of 20 studies from European, <xref ref-type="bibr" rid="pone.0113363-Gardemann1">[2]</xref>, <xref ref-type="bibr" rid="pone.0113363-Alvarez1">[27]</xref>, <xref ref-type="bibr" rid="pone.0113363-Wang1">[33]</xref>, <xref ref-type="bibr" rid="pone.0113363-Granath1">[37]</xref>, <xref ref-type="bibr" rid="pone.0113363-Jaramillo2">[39]</xref>, <xref ref-type="bibr" rid="pone.0113363-Agema1">[54]</xref>, <xref ref-type="bibr" rid="pone.0113363-Fatini1">[55]</xref>, <xref ref-type="bibr" rid="pone.0113363-Rios2">[57]</xref>, <xref ref-type="bibr" rid="pone.0113363-Sampaio1">[58]</xref>, <xref ref-type="bibr" rid="pone.0113363-Vasilakou1">[61]</xref>, <xref ref-type="bibr" rid="pone.0113363-daCostaEscobarPiccoli1">[64]</xref>, <xref ref-type="bibr" rid="pone.0113363-Dosenko1">[91]</xref>, <xref ref-type="bibr" rid="pone.0113363-Meluzin1">[93]</xref>, <xref ref-type="bibr" rid="pone.0113363-Fowkes1">[99]</xref>–<xref ref-type="bibr" rid="pone.0113363-Kincl1">[105]</xref> 8 from Middle Eastern, <xref ref-type="bibr" rid="pone.0113363-Cine1">[34]</xref>, <xref ref-type="bibr" rid="pone.0113363-Kallel1">[76]</xref>, <xref ref-type="bibr" rid="pone.0113363-Matyar1">[106]</xref>–<xref ref-type="bibr" rid="pone.0113363-Ekmekci1">[111]</xref> 10 from Asian, <xref ref-type="bibr" rid="pone.0113363-Hibi1">[11]</xref>, <xref ref-type="bibr" rid="pone.0113363-Kim1">[22]</xref>, <xref ref-type="bibr" rid="pone.0113363-Ichihara1">[35]</xref>, <xref ref-type="bibr" rid="pone.0113363-Park1">[36]</xref>, <xref ref-type="bibr" rid="pone.0113363-Lin1">[80]</xref>, <xref ref-type="bibr" rid="pone.0113363-Bae1">[82]</xref>, <xref ref-type="bibr" rid="pone.0113363-Odawara1">[112]</xref>–<xref ref-type="bibr" rid="pone.0113363-Hwang1">[115]</xref> 2 from Asian-Indian <xref ref-type="bibr" rid="pone.0113363-Narne1">[90]</xref>, <xref ref-type="bibr" rid="pone.0113363-Gururajan1">[116]</xref> and 3 from African <xref ref-type="bibr" rid="pone.0113363-Rios2">[57]</xref>, <xref ref-type="bibr" rid="pone.0113363-Hooper1">[98]</xref>, <xref ref-type="bibr" rid="pone.0113363-Rao1">[104]</xref> group were included for subgroup analysis. (<xref ref-type="table" rid="pone-0113363-t002"><bold>Table 2</bold></xref>) Middle Eastern, Asian and African groups showed considerably low heterogeneity among the three genetic models (<italic>I<sup>2</sup> range</italic> = 0–33%; P<sub>Q</sub> range = 0.18–0.83), while European and Asian-Indian groups showed very low to very high heterogeneity (<italic>I<sup>2</sup> range</italic> = 0–87%; P<sub>Q</sub> range = 0.72–0.005). (<xref ref-type="table" rid="pone-0113363-t002"><bold>Table 2</bold></xref>) The Middle Eastern and Asian groups showed significant association in all three models. It is however noteworthy that the Middle Eastern subgroup showed stronger association (OR range = 1.71–3.02, Z value range = 4.65–7.09, P&lt;0.0001 for all comparisons) than the Asian subgroup (OR range = 1.22–2.48, Z value range = 2.45–3.06, P≤0.01 for all comparisons) consistently in all three models. African group showed moderate association limited only to recessive and allelic models (OR range = 1.37–2.02, Z value range = 2.07–2.34, P≤0.02), whereas Asian-Indian group showed marginal association in only the recessive genetic model (OR = 2.63, Z value = 1.99, P value = 0.05). The European group however showed no association in any of the three genetic models (P&gt;0.05). (<xref ref-type="table" rid="pone-0113363-t003"><bold>Table 3</bold></xref><bold> and </bold><xref ref-type="fig" rid="pone-0113363-g004"><bold>Figures 4</bold></xref><bold>, <xref ref-type="supplementary-material" rid="pone.0113363.s005">S5</xref> and <xref ref-type="supplementary-material" rid="pone.0113363.s006">S6</xref></bold>)</p>
</sec></sec><sec id="s3d">
<title>Source of heterogeneity</title>
<p>Higher degree of heterogeneity was seen amongst almost all ancestral groups (except Asian-Indians) in all comparisons for Glu298Asp polymorphism. All groups were fairly heterogeneous in all comparisons for T786-C polymorphism. Fairly low heterogeneity was seen amongst Middle Eastern and Asian groups in all comparisons for 4b/a polymorphism. (<xref ref-type="table" rid="pone-0113363-t002"><bold>Table 2</bold></xref>) Environmental factors like diet, exercise etc. could be the probable reasons behind seen heterogeneity among the groups. We did all we could by classifying studies into five broad subgroups, based on predominant ancestry, in order to determine sources of heterogeneity. Further classification would have only made the samples in each subgroup smaller and their results impotent. (<xref ref-type="table" rid="pone-0113363-t002"><bold>Table 2</bold></xref>)</p>
</sec><sec id="s3e">
<title>Potential publication Bias</title>
<p>Potential publication bias among groups of studies for each SNP was assessed by two different statistical tests, viz. Egger's plots <xref ref-type="bibr" rid="pone.0113363-Egger1">[51]</xref> and Begg's funnel plots. <xref ref-type="bibr" rid="pone.0113363-Begg1">[50]</xref> The recessive genetic model showed least heterogeneity for all three SNPs among all ethnic groups (as seen in <xref ref-type="table" rid="pone-0113363-t002"><bold>Table 2</bold></xref>), its data was thus selected to generate Egger's plots. No asymmetry in plots was seen for Glu298Asp or 4b/a for the pooled group or any of its ancestral subgroups. Egger's P values for Glu298Asp were 0.56, 0.11, 0.08, 0.42 and 0.56 respectively for pooled and European, Middle Eastern, Asian and Asian Indian subgroups. Similarly Egger's P values for 4b/a were 0.79, 0.15, 0.85, 0.92, 0.88 for pooled and European, Middle Eastern, Asian and African subgroups. Owing to less number of studies (n&lt;3), no P value from Egger's test was generated in African subgroup of Glu298Asp and Asian-Indian subgroup of 4/a polymorphism. In case of T786-C, Egger's plot asymmetry was however seen for pooled (P = 0.002) and European (P = 0.004) subgroup. Rest of the two subgroups showed either symmetry in their plots (P = 0.71 and 0.91 for Middle Eastern and Asian groups respectively) or were their p values was incalculable (i.e. for Asian-Indian and African groups).</p>
<p>Begg's funnel plots, <xref ref-type="bibr" rid="pone.0113363-Begg1">[50]</xref> were also generated to assess potential publication bias for each SNP in their three genetic models. Funnel plots are provided for pooled analysis obtained in allelic comparisons for all three studied polymorphisms. (<xref ref-type="fig" rid="pone-0113363-g005"><bold>Figure 5-A, B, C</bold></xref>) Plots for dominant and recessive models for all three SNPs are also provided as (<bold><xref ref-type="supplementary-material" rid="pone.0113363.s007">Figures S7-A, B</xref>; <xref ref-type="supplementary-material" rid="pone.0113363.s008">S8-A, B</xref>; <xref ref-type="supplementary-material" rid="pone.0113363.s009">S9-A, B</xref></bold>). Each point in the figure represents OR of a study plotted against standard error (SE) of OR of that particular study. Different indicators of the studies belonging to each ancestry are used in these plots where they are seen to be generally contained within the inverted cone, indicating no significant publication bias, at least in the pooled analyses.</p>
<fig id="pone-0113363-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0113363.g005</object-id><label>Figure 5</label><caption>
<title>Begg's funnel plots for testing publication bias in Allelic comparisons.</title>
<p>Each point in each figure represents OR of a study plotted against the standard error (SE) its OR. Different indicators of the studies belonging to each ancestral group are used in these plots. <bold>Figure 5A</bold>: <italic>Allele T vs. G</italic> for Glu298Asp; <bold>Figure 5B</bold>: <italic>Allele C vs. T</italic> for T786-C; <bold>Figure 5C</bold>: <italic>Allele 4a vs. 4b</italic> for 4b/a.</p>
</caption><graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0113363.g005" position="float" xlink:type="simple"/></fig></sec><sec id="s3f">
<title>Sensitivity Analysis</title>
<p>Sensitivity analysis was performed in each study group in every genetic model, where we excluded studies one after another and conducted the analysis after each omission. The results in none of the groups and studied genetic models altered substantially to change the results from no association to significant association or the other way around (in groups of ≥5 studies). This indicates that the present meta-analysis is robust in nature.</p>
</sec></sec><sec id="s4">
<title>Discussion</title>
<p>The present meta-analysis and structured systematic review is the most comprehensive till date and comprises of published studies which investigated the association of three most common <italic>NOS3</italic> gene polymorphisms, (i.e. Glu298Asp, 4b/a and T786-C) with CAD.</p>
<p>All comparisons in the pooled analysis for all three SNPs indicated significant association with CAD. The pooled results of Glu298Asp suggested that the presence of even a single T allele in a genotype effects in an increased risk of CAD. The risk of CAD is even higher if the genotype contains more than 1, T allele. This association is evident by the obtained pooled OR in allelic comparison (OR = 1.29, Z value = 6.33 and p&lt;0.00001). (<xref ref-type="table" rid="pone-0113363-t003"><bold>Table 3</bold></xref><bold> and </bold><xref ref-type="fig" rid="pone-0113363-g002"><bold>Figure 2</bold></xref>) The same pattern of association is seen for almost all the ancestral groups (except Africans), where generally higher ORs are seen in recessive models as compared to their dominant models. (<xref ref-type="table" rid="pone-0113363-t003"><bold>Table 3</bold></xref><bold> and <xref ref-type="supplementary-material" rid="pone.0113363.s001">Figures S1</xref> and <xref ref-type="supplementary-material" rid="pone.0113363.s002">S2</xref></bold>) Consistent to the seen pattern, the T allele also showed a significant association with CAD in almost all ancestral groups, barring the Africans which had only 1 study. (<xref ref-type="table" rid="pone-0113363-t003"><bold>Table 3</bold></xref><bold> and </bold><xref ref-type="fig" rid="pone-0113363-g002"><bold>Figure 2</bold></xref>) In the case of T786-C polymorphism, our pooled as well as subgroup results also suggested an increased risk in genotypes carrying the minor (C) allele. All three genetic models showed significant association in the pooled analysis. Significant association was also seen in all ancestral subgroups in at least two out of three genetic models. As in the case of Glu298Asp, the risk increased in genotypes of T786-C, which were homozygous to the C allele. However, contrary to the trends seen in case of Glu298Asp and 4b/a, we observed that for T786-C, Asians followed by Europeans showed highest degree of associations across all three genetic models. (<xref ref-type="table" rid="pone-0113363-t003"><bold>Table 3</bold></xref><bold> and </bold><xref ref-type="fig" rid="pone-0113363-g003"><bold>Figure 3</bold></xref>) The presence of 4a allele of 4b/a polymorphism resulted in an increased risk for CAD in the pooled analysis (OR = 1.20) and specifically among two ancestral groups viz. Middle Eastern (OR = 1.71) and Asian (OR = 1.25). (<xref ref-type="table" rid="pone-0113363-t003"><bold>Table 3</bold></xref><bold> and </bold><xref ref-type="fig" rid="pone-0113363-g004"><bold>Figure 4</bold></xref>) Here too, genotypes carrying &gt;1, 4a alleles showed notably higher risk in pooled analysis as well as in the Middle Eastern and Asian subgroups. The pooled as well as the Middle Eastern and Asian subgroups also showed significant association in the allelic model. As far as the 4b/a polymorphism is concerned, Africans showed significant association in recessive and allelic model, while Asian-Indians showed a hint of association in the recessive model. (<xref ref-type="table" rid="pone-0113363-t003"><bold>Table 3</bold></xref><bold> and </bold><xref ref-type="fig" rid="pone-0113363-g004"><bold>Figures 4</bold></xref><bold>, <xref ref-type="supplementary-material" rid="pone.0113363.s005">S5</xref> and <xref ref-type="supplementary-material" rid="pone.0113363.s006">S6</xref></bold>)</p>
<p>Our pooled analysis showed significant associations of all three selected SNPs with CAD in every employed genetic model. Our results are in contrast to the previously published meta-analysis (for all three selected SNPs), <xref ref-type="bibr" rid="pone.0113363-Li1">[40]</xref> which was not able to deduce any significant associations for T786-C and 4b/a and only showed significant association for Glu298Asp under dominant genetic model. One reason for the difference in the results of the present study and the study by Li et al., <xref ref-type="bibr" rid="pone.0113363-Li1">[40]</xref> can be the sheer number of studies included. Since the year 2010 when the study by Li et al. <xref ref-type="bibr" rid="pone.0113363-Li1">[40]</xref> was published, a number of studies came out in the public domain among which several of them reported statistically significant associations. This previous meta-analysis <xref ref-type="bibr" rid="pone.0113363-Li1">[40]</xref> included a much lesser number of studies, thus making the present study a more comprehensive one (56 vs. 132 studies in previous vs. present study respectively). Several other recent meta-analyses which assessed either one of the three <italic>NOS3</italic> SNPs are also now into public domain. <xref ref-type="bibr" rid="pone.0113363-Zhang1">[41]</xref>–<xref ref-type="bibr" rid="pone.0113363-Yang1">[44]</xref> The pooled analysis for Glu298Asp in the meta-analysis by Tian et al., <xref ref-type="bibr" rid="pone.0113363-Tian1">[43]</xref> reported significant associations in dominant (OR = 1.17), recessive (OR = 1.59) and allelic (OR = 1.26) models which are somewhat comparable to those deduced in our study. In the meta-analysis by Tian et al. <xref ref-type="bibr" rid="pone.0113363-Tian1">[43]</xref>, the Asian subgroup for Glu298Asp showed significant association to CHD in all employed genetic models, the effect sizes of which are similar to those deduced for the Asian subgroup in the present study. There is also a meta-analysis by Zhang et al., <xref ref-type="bibr" rid="pone.0113363-Zhang1">[41]</xref> who reported significant association (with OR = 1.52), in allelic comparisons of Glu298Asp among Asians, the effect size of which is similar to that deduced in our study (OR = 1.51). We also obtained similar results for Asian subgroup with another previously published meta-analysis for T786-C <xref ref-type="bibr" rid="pone.0113363-Liu1">[42]</xref>. In fact our study can be considered as an improvement on all the previously published meta-analyses on polymorphic forms of <italic>NOS3</italic> gene and CAD, <xref ref-type="bibr" rid="pone.0113363-Li1">[40]</xref>–<xref ref-type="bibr" rid="pone.0113363-Yang1">[44]</xref> not only in the terms of higher number of studies included but also in terms of better classification of ancestral groups and assessment of their individual risk. This allowed us to unravel the degree of associations among several other important ancestral groups such as Middle Easterners and Asian-Indians apart from Europeans and Asians which were already amply investigated by several previously published meta-analyses.</p>
<p>There are basically two major merits of the present study which makes it superior to all previously published meta-analyses on this subject. <xref ref-type="bibr" rid="pone.0113363-Li1">[40]</xref>–<xref ref-type="bibr" rid="pone.0113363-Yang1">[44]</xref> Firstly, our study is the most comprehensive till date and we ended up including most number of individual studies which transcribed into the largest sample size ever studied for each of the three <italic>NOS3</italic> SNPs. Secondly, our study had strict inclusion/exclusion criteria, and we excluded studies with surrogate endpoints, and omitted studies in which controls did not conform to HWE proportions (most of which were included in previously published meta-analyses). This methodology ensured that we eliminated studies with potentially biased/inaccurate results, thus possibly presenting a real picture.</p>
<p>The biochemical basis of the association of CAD with various <italic>NOS3</italic> gene polymorphisms has been studied in detail by several researchers. Most schools of thought suggest that all these SNPs of <italic>NOS3</italic> gene viz. Glu298Asp, T786-C and 4b/a 27bp VNTR via various mechanisms affect the serum nitrite/nitrate (NO<italic><sub>x</sub></italic>) concentrations in the human body. Over a period of time this imbalance in NO<italic><sub>x</sub></italic> concentrations results in “endothelial dysfunction” which finally blooms into an overt form of CAD. It is plausible that this degree of association with CAD and the resulting NO<italic><sub>x</sub></italic> concentrations are affected by gene-gene, gene-environment interactions. Compensatory mechanism of the human body against CAD may also increase NO secretion from the vascular endothelium during sudden reperfusion after acute coronary syndromes. <xref ref-type="bibr" rid="pone.0113363-Salom1">[117]</xref>, <xref ref-type="bibr" rid="pone.0113363-Kelm1">[118]</xref> Therefore it remains unclear whether the increase in NO levels is a “cause” or an “effect” of acute coronary syndromes. Clearly the association between these SNPs and CAD, probably also has different biochemical basis rather than solely brought about by variations in NO<italic><sub>x</sub></italic> concentrations.</p>
<p>Positive association of Glu298Asp with CAD/MI has been reported over the years in several published studies. We found that along with a significant association for all three genetic models in our pooled analysis, this SNP seen to be associated with CAD separately among all ancestral groups, with the highest degree of association seen amongst the Middle Easterners.(<xref ref-type="table" rid="pone-0113363-t003"><bold>Table 3</bold></xref><bold> and </bold><xref ref-type="fig" rid="pone-0113363-g002"><bold>Figures 2</bold></xref><bold>, <xref ref-type="supplementary-material" rid="pone.0113363.s001">S1</xref> and <xref ref-type="supplementary-material" rid="pone.0113363.s002">S2</xref></bold>) The reason of this differential risk of CAD seen among different ancestral groups carrying this polymorphism is unknown and should be investigated upon. We presume that this difference could had been brought about by the variance in Asp allele frequency (range = 0.04-0.39), as well as several known and unknown gene-gene and gene-environment interactions. The biochemical basis of the association of CAD with Asp allele carriers has although been extensively studied upon however a clear consensus is still lacking. Some studies have reported an association of this SNP with intracellular NO concentration. <xref ref-type="bibr" rid="pone.0113363-Philip1">[12]</xref> The mechanism by which the Asp allele possibly reduces NO bioavailability in the human body has also been hypothesized. It has been suggested that the Asp298 is subjected to selective proteolytic cleavage in the endothelial cells and vascular tissues. <xref ref-type="bibr" rid="pone.0113363-Tesauro1">[119]</xref>, <xref ref-type="bibr" rid="pone.0113363-Persu1">[120]</xref> The resultant cleaved fragments especially among the homozygous mutants of this SNP are expected to lack NO synthase activity <xref ref-type="bibr" rid="pone.0113363-Angeline1">[13]</xref> thus reducing bioavailability of NO in the body. <xref ref-type="bibr" rid="pone.0113363-Tesauro1">[119]</xref>, <xref ref-type="bibr" rid="pone.0113363-Persu1">[120]</xref> Contrary to this notion several studies <xref ref-type="bibr" rid="pone.0113363-Angeline1">[13]</xref>, <xref ref-type="bibr" rid="pone.0113363-BorKucukatay1">[14]</xref>, <xref ref-type="bibr" rid="pone.0113363-Afrasyap1">[67]</xref> have reported lack of association of plasma NO<italic><sub>x</sub></italic> concentrations with any of the genotypes or alleles for this SNP. Also, since these associations are often masked, as it is affected by several physiological and pathological conditions, the real effect of <italic>NOS3</italic> gene on plasma NO<italic><sub>x</sub></italic> levels is hard to determine. <xref ref-type="bibr" rid="pone.0113363-BorKucukatay1">[14]</xref> As already discussed genotypes carrying Asp alleles impart greater RBC aggregability. <xref ref-type="bibr" rid="pone.0113363-BorKucukatay1">[14]</xref> Genotypes having Asp alleles have also been shown to have (i) a reduced blood pressure fall after exercise training, <xref ref-type="bibr" rid="pone.0113363-Rankinen1">[121]</xref> (ii) an enhanced systemic presser response to phenylephrine <xref ref-type="bibr" rid="pone.0113363-Philip1">[12]</xref> (iii) lower basal blood flow and reduced vasodilation to adenosine in coronary arteries <xref ref-type="bibr" rid="pone.0113363-Naber1">[122]</xref> and (iv) a reduced flow-mediated dilatation of the brachial artery, <xref ref-type="bibr" rid="pone.0113363-Savvidou1">[123]</xref> making them more prone to suffer from coronary events. It is possible that these effects coupled with possible modulation in bioavailability of NO in presence of interactions with other genes and environmental factors may accelerate the process of endothelial dysfunction and subsequent emergence of overt CAD among Asp variants of the <italic>NOS3</italic> gene.</p>
<p>The T786-C gene variant of <italic>NOS3</italic> has also been implicated over the years with CAD occurrence by several investigators. Along with a significant association among all three genetic models in our pooled analysis, Asians seemed to have strongest association with CAD than other ancestral groups. (<xref ref-type="table" rid="pone-0113363-t003"><bold>Table 3</bold></xref><bold>, </bold><xref ref-type="fig" rid="pone-0113363-g003"><bold>Figure 3</bold></xref><bold>, <xref ref-type="supplementary-material" rid="pone.0113363.s003">S3</xref> and <xref ref-type="supplementary-material" rid="pone.0113363.s004">S4</xref></bold>) The reason behind this dissimilar degree of association among these ancestral groups is unknown. More in depth studies are warranted to answer this pertinent question. In vitro reporter gene assays performed by Nakayama et al., <xref ref-type="bibr" rid="pone.0113363-Nakayama1">[24]</xref> somewhat explained the possible functional effect of this SNP. They demonstrated that T786-C mutation reduces the promoter activity by as high as 50%, suggesting that in several C allele carriers the L-arginine/NO pathway does not function properly, reducing NO concentrations and causing endothelial dysfunction. <xref ref-type="bibr" rid="pone.0113363-Nakayama1">[24]</xref> Other studies have also shown lower <italic>NOS3</italic> mRNA and serum NO<italic><sub>x</sub></italic> levels in genotypes with ≥1, 786C alleles, <xref ref-type="bibr" rid="pone.0113363-Miyamoto2">[26]</xref> although contradictory results have also been published. <xref ref-type="bibr" rid="pone.0113363-Jeerooburkhan1">[124]</xref> Apart from lower NOx concentrations <xref ref-type="bibr" rid="pone.0113363-Miyamoto2">[26]</xref>, synergistic effect of <italic>NOS3</italic> Glu298Asp and T786-C polymorphism has also been reported to be the cause of increased CAD risk among carriers of this SNP. <xref ref-type="bibr" rid="pone.0113363-Colombo2">[5]</xref></p>
<p>Clear scientific evidence is lacking which can explain the seen association of <italic>NOS3</italic> 4b/a VNTR polymorphism with CAD. In contrast to the previous studies, <xref ref-type="bibr" rid="pone.0113363-Li1">[40]</xref>, <xref ref-type="bibr" rid="pone.0113363-Yang1">[44]</xref> the pooled results of our study yielded significant association amongst all three genetic models. Highest degree of association among the Middle Eastern group was seen in all three genetic models. (<xref ref-type="table" rid="pone-0113363-t002"><bold>Table 2</bold></xref><bold> and </bold><xref ref-type="fig" rid="pone-0113363-g004"><bold>Figures 4</bold></xref><bold>, <xref ref-type="supplementary-material" rid="pone.0113363.s005">S5</xref> and <xref ref-type="supplementary-material" rid="pone.0113363.s006">S6</xref></bold>) The precise reason of this heightened risk amongst subjects of Middle Eastern ancestry is unknown and can only be speculated upon. Here again the influence of environmental factors such as diet and exercise may well be associated with the increased risk. Conflicting reports between the intron-4 variant and NO pathway activity are there in the public domain. Genotypes carrying ≥1 mutant alleles have been shown to have lower plasma NO levels and reduced protein expression, <xref ref-type="bibr" rid="pone.0113363-Tsukada1">[125]</xref>, <xref ref-type="bibr" rid="pone.0113363-Wang3">[126]</xref> although some studies have demonstrated otherwise. <xref ref-type="bibr" rid="pone.0113363-Yoon1">[77]</xref>, <xref ref-type="bibr" rid="pone.0113363-Jeerooburkhan1">[124]</xref>, <xref ref-type="bibr" rid="pone.0113363-Wang4">[127]</xref> As this polymorphism is located in the intron region of the gene, even if it is not functional it might act as a risk factor and act in linkage disequilibrium with other regulatory regions and functional gene variants of the <italic>NOS3</italic> gene. <xref ref-type="bibr" rid="pone.0113363-Jeerooburkhan1">[124]</xref></p>
<p>We believe that the present study has successfully answered the research question that it aimed at the outset and is statistically powered enough to the stand by the results it obtained. Although, there is a scope for limitations in every meta-analysis of genetic association studies and ours was no exception either. Firstly, we believe that there was under representation of the South-Asian region, and we found no published data on the subject from several South-Asian countries like Bangladesh, Sri Lanka and Pakistan etc., which have a sizable population inflicted with CAD. Secondly possibility of errors in genotyping, presence of selection bias and risk of inadequate sample size among different studies cannot be ruled out. It is also noteworthy that in case of polygenic diseases like CAD, an association study cannot test causality, it can merely measure statistical associations. Also, during meta-analysis of association studies we cannot ensure interference of linkage disequilibrium of the selected SNP with another closely linked site and its extent of effect on the overall association. Even after using two statistical tools, we could not detect any hint of publication bias amongst our study groups, at least for Glu298Asp and 4b/a polymorphisms. However, Egger's plot asymmetry was observed, with significant p values for pooled and European subgroup of T786-C polymorphism. Since the accuracy of Egger's test is debatable, and this asymmetry in the aforementioned plots could have possibly been due to factors like inter-study variations or small study effects among European subgroup for T786-C. Even then, the role of existing publication bias cannot be completely ruled out. This also qualifies to be listed as another small limitation in the present study.</p>
</sec><sec id="s5">
<title>Conclusions</title>
<p>In conclusion, since the criteria for inclusion and exclusion of studies are critical parts of a meta-analysis and can substantially affect results, we find that the present study is the most comprehensive till date and is systematically planned to funnel out erroneous studies. We thus feel that our study projects the real picture, and confirms the association of the three common <italic>NOS3</italic> gene polymorphisms i.e. Glu298Asp, T786-C and 4a/b VNTR with CAD transcending all ancestries worldwide. Results amongst different ancestral subgroups were rather illuminating. Amongst the studied <italic>NOS3</italic> SNPs, both Glu298Asp and 4b/a showed strongest association among the Middle Eastern subgroup. On the other hand, T786-C and its minor allele seem to carry the highest risk for CAD among subjects of Asian ancestry. Our study significantly improves the understanding of the relation between this gene and CAD and its association amongst subjects of all major ancestries. These findings should thenceforth be assessed clinically for its implications in prevention and treatment strategies of CAD.</p>
</sec><sec id="s6">
<title>Supporting Information</title>
<supplementary-material id="pone.0113363.s001" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pone.0113363.s001" position="float" xlink:type="simple"><label>Figure S1</label><caption>
<p><bold>Forest plot depicting results of meta-analysis of studies reporting </bold><bold><italic>NOS3</italic></bold><bold> Glu298Asp polymorphism assessed under dominant </bold><bold><italic>(TT+GT vs. GG)</italic></bold><bold> genetic model.</bold> Effect size estimates for all ancestral groups in this plot were obtained using random effects for analysis. Effect sizes using fixed effects were recalculated for Asian-Indian group which showed homogenous distribution among its included studies. Recalculated effect size estimate for Asian-Indians was, OR, 95%CI = 1.21, 1.01–1.45; Z = 2.07; P = 0.04.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pone.0113363.s002" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pone.0113363.s002" position="float" xlink:type="simple"><label>Figure S2</label><caption>
<p><bold>Forest plot depicting results of meta-analysis of studies reporting </bold><bold><italic>NOS3</italic></bold><bold> Glu298Asp polymorphism assessed under recessive </bold><bold><italic>(TT vs. GG+GT)</italic></bold><bold> genetic model.</bold> Effect size estimates for all ancestral groups in this plot were obtained using random effects for analysis. Effect sizes using fixed effects were recalculated for Asian and Asian-Indian groups which showed homogenous distribution among its included studies. Recalculated effect size estimates were, OR, 95%CI = 2.22, 1.21–4.08; Z = 2.57; P = 0.01 and OR, 95%CI = 1.85, 1.12–3.04; Z = 2.42; P = 0.02 for Asians and Asian-Indians respectively.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pone.0113363.s003" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pone.0113363.s003" position="float" xlink:type="simple"><label>Figure S3</label><caption>
<p><bold>Forest plot depicting results of meta-analysis of studies reporting </bold><bold><italic>NOS3</italic></bold><bold> T786-C polymorphism assessed under dominant </bold><bold><italic>(CC+CT vs. TT)</italic></bold><bold> genetic model.</bold> Effect size estimates for all ancestral groups in this plot were obtained using random effects for analysis.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pone.0113363.s004" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pone.0113363.s004" position="float" xlink:type="simple"><label>Figure S4</label><caption>
<p><bold>Forest plot depicting results of meta-analysis of studies reporting </bold><bold><italic>NOS3</italic></bold><bold> T786-C polymorphism assessed under recessive </bold><bold><italic>(CC vs. TT+CT)</italic></bold><bold> genetic model.</bold> Effect size estimates for all ancestral groups in this plot were obtained using fixed effects for analysis. Effect sizes using random effects were recalculated for three ancestral subgroups viz. Middle Eastern, Asian-Indian and African, which showed homogenous distribution among its included studies. Recalculated effect size estimates were, OR, 95%CI = 1.35, 0.69-2.65; Z = 0.87; P = 0.38 for Middle Easterners; OR, 95%CI = 1.73, 0.38–7.95; Z = 0.71; P = 0.48 for Asian-Indians and OR, 95%CI = 1.85, 0.77–4.44; Z = 1.37; P = 0.17 for Africans.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pone.0113363.s005" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pone.0113363.s005" position="float" xlink:type="simple"><label>Figure S5</label><caption>
<p><bold>Forest plot depicting results of meta-analysis of studies reporting </bold><bold><italic>NOS3</italic></bold><bold> 4b/a VNTR polymorphism assessed under dominant </bold><bold><italic>(4a4a+4a4b vs. 4b4b)</italic></bold><bold> genetic model.</bold> Effect size estimates for all ancestral groups in this plot were obtained using random effects for analysis. Effect sizes using fixed effects were recalculated for Middle Eastern and Asian groups which showed homogenous distribution among its included studies. Recalculated effect size estimates were, OR, 95%CI = 1.73, 1.46–2.05; Z = 6.28; P = &lt;0.00001 and OR, 95%CI = 1.22, 1.04–1.42; Z = 2.45; P = 0.01 for Middle Easterners and Asians respectively.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pone.0113363.s006" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pone.0113363.s006" position="float" xlink:type="simple"><label>Figure S6</label><caption>
<p><bold>Forest plots depicting results of meta-analysis of studies reporting </bold><bold><italic>NOS3</italic></bold><bold> 4b/a VNTR polymorphism assessed under recessive </bold><bold><italic>(4a4a vs. 4a4b+4b4b)</italic></bold><bold> genetic model.</bold> Since all the ancestral groups showed homogenous distribution among its included studies, effect size estimates for all groups in this plot were obtained using fixed effects for analysis.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pone.0113363.s007" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pone.0113363.s007" position="float" xlink:type="simple"><label>Figure S7</label><caption>
<p><bold>Begg's funnel plots for testing publication bias in comparisons under different genetic models for </bold><bold><italic>NOS3</italic></bold><bold> Glu298Asp polymorphism.</bold> Each point in each figure represents OR of a study plotted against the standard error (SE) its OR. Different indicators of the studies belonging to each ancestral group are used in these plots. <bold><xref ref-type="supplementary-material" rid="pone.0113363.s007">Figure S7A</xref></bold>: Begg's Plot for comparisons under dominant genetic model <italic>(TT+GT vs. GG)</italic>; <bold><xref ref-type="supplementary-material" rid="pone.0113363.s007">Figure S7B</xref></bold>: Begg's Plot for comparisons under recessive genetic model <italic>(TT vs. GG+GT)</italic>.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pone.0113363.s008" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pone.0113363.s008" position="float" xlink:type="simple"><label>Figure S8</label><caption>
<p><bold>Begg's funnel plots for testing publication bias in comparisons under different genetic models for </bold><bold><italic>NOS3</italic></bold><bold> T786-C polymorphism.</bold> Each point in each figure represents OR of a study plotted against the standard error (SE) its OR. Different indicators of the studies belonging to each ancestral group are used in these plots. <bold><xref ref-type="supplementary-material" rid="pone.0113363.s008">Figure S8A</xref></bold>: Begg's Plot for comparisons under dominant genetic model <italic>(CC+CT vs. TT)</italic>; <bold><xref ref-type="supplementary-material" rid="pone.0113363.s008">Figure S8B</xref></bold>: Begg's Plot for comparisons under recessive genetic model <italic>(CC vs. TT+CT)</italic>.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pone.0113363.s009" mimetype="image/tiff" xlink:href="info:doi/10.1371/journal.pone.0113363.s009" position="float" xlink:type="simple"><label>Figure S9</label><caption>
<p><bold>Begg's funnel plots for testing publication bias in comparisons under different genetic models for </bold><bold><italic>NOS3</italic></bold><bold> 4b/a VNTR gene polymorphism.</bold> Each point in each figure represents OR of a study plotted against the standard error (SE) its OR. Different indicators of the studies belonging to each ancestral group are used in these plots. <bold><xref ref-type="supplementary-material" rid="pone.0113363.s009">Figure S9A</xref></bold>: Begg's Plot for comparisons under dominant genetic model <italic>(4a4a+4a4b vs. 4b4b)</italic>; <bold><xref ref-type="supplementary-material" rid="pone.0113363.s009">Figure S9B</xref></bold>: Begg's Plot for comparisons under recessive genetic model <italic>(4a4a vs. 4a4b+4b4b)</italic>.</p>
<p>(TIF)</p>
</caption></supplementary-material><supplementary-material id="pone.0113363.s010" mimetype="application/zip" xlink:href="info:doi/10.1371/journal.pone.0113363.s010" position="float" xlink:type="simple"><label>Data S1</label><caption>
<p><bold>The raw data collected from all the published association studies included in the present meta-analysis.</bold></p>
<p>(ZIP)</p>
</caption></supplementary-material><supplementary-material id="pone.0113363.s011" mimetype="application/msword" xlink:href="info:doi/10.1371/journal.pone.0113363.s011" position="float" xlink:type="simple"><label>Checklist S1</label><caption>
<p><bold>PRISMA Checklist.</bold></p>
<p>(DOC)</p>
</caption></supplementary-material></sec></body>
<back><ref-list>
<title>References</title>
<ref id="pone.0113363-Moncada1"><label>1</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Moncada</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Higgs</surname><given-names>A</given-names></name> (<year>1993</year>) <article-title>The L-arginine-nitric oxide pathway</article-title>. <source>N Engl J Med</source> <volume>329(27)</volume>: <fpage>2002</fpage>–<lpage>2012</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Gardemann1"><label>2</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gardemann</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lohre</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Cayci</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Katz</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Tillmanns</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>The T allele of the missense Glu(298)Asp endothelial nitric oxide synthase gene polymorphism is associated with coronary heart disease in younger individuals with high atherosclerotic risk profile</article-title>. <source>Atherosclerosis</source> <volume>160(1)</volume>: <fpage>167</fpage>–<lpage>175</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Hingorani1"><label>3</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hingorani</surname><given-names>AD</given-names></name>, <name name-style="western"><surname>Liang</surname><given-names>CF</given-names></name>, <name name-style="western"><surname>Fatibene</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lyon</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Monteith</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>1999</year>) <article-title>A common variant of the endothelial nitric oxide synthase (Glu298—&gt;Asp) is a major risk factor for coronary artery disease in the UK</article-title>. <source>Circulation</source> <volume>100(14)</volume>: <fpage>1515</fpage>–<lpage>1520</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Colombo1"><label>4</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Colombo</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Andreassi</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Paradossi</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Botto</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Manfredi</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Evidence for association of a common variant of the endothelial nitric oxide synthase gene (Glu298—&gt;Asp polymorphism) to the presence, extent, and severity of coronary artery disease</article-title>. <source>Heart</source> <volume>87(6)</volume>: <fpage>525</fpage>–<lpage>528</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Colombo2"><label>5</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Colombo</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Paradossi</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Andreassi</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Botto</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Manfredi</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Endothelial nitric oxide synthase gene polymorphisms and risk of coronary artery disease</article-title>. <source>Clin Chem</source> <volume>49(3)</volume>: <fpage>389</fpage>–<lpage>395</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Marsden1"><label>6</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Marsden</surname><given-names>PA</given-names></name>, <name name-style="western"><surname>Heng</surname><given-names>HH</given-names></name>, <name name-style="western"><surname>Scherer</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Stewart</surname><given-names>RJ</given-names></name>, <name name-style="western"><surname>Hall</surname><given-names>AV</given-names></name>, <etal>et al</etal>. (<year>1993</year>) <article-title>Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene</article-title>. <source>J Biol Chem</source> <volume>268(23)</volume>: <fpage>17478</fpage>–<lpage>17488</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Hingorani2"><label>7</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hingorani</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Jia</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Stevens</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Monteith</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Brown</surname><given-names>M</given-names></name> (<year>1995</year>) <article-title>A Common Variant in Exon 7 of the Endothelial Constitutive Nitric Oxide Synthase Gene: Identification by Single Strand Conformation Polymorphism Analysis</article-title>. <source>Clinical Science 88(Pt</source> <volume>s32)</volume>: <fpage>21P</fpage>–<lpage>21P</lpage> (Abstract)..</mixed-citation>
</ref>
<ref id="pone.0113363-Yoshimura1"><label>8</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yoshimura</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yasue</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Nakayama</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Shimasaki</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Sumida</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>1998</year>) <article-title>A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese</article-title>. <source>Hum Genet</source> <volume>103(1)</volume>: <fpage>65</fpage>–<lpage>69</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Miyamoto1"><label>9</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Miyamoto</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Saito</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kajiyama</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Yoshimura</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Shimasaki</surname><given-names>Y</given-names></name>, <etal>et al</etal>. (<year>1998</year>) <article-title>Endothelial nitric oxide synthase gene is positively associated with essential hypertension</article-title>. <source>Hypertension</source> <volume>32(1)</volume>: <fpage>3</fpage>–<lpage>8</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Shimasaki1"><label>10</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shimasaki</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yasue</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Yoshimura</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nakayama</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kugiyama</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>1998</year>) <article-title>Association of the missense Glu298Asp variant of the endothelial nitric oxide synthase gene with myocardial infarction</article-title>. <source>J Am Coll Cardiol</source> <volume>31(7)</volume>: <fpage>1506</fpage>–<lpage>1510</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Hibi1"><label>11</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hibi</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Ishigami</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Tamura</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Mizushima</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Nyui</surname><given-names>N</given-names></name>, <etal>et al</etal>. (<year>1998</year>) <article-title>Endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction</article-title>. <source>Hypertension</source> <volume>32(3)</volume>: <fpage>521</fpage>–<lpage>526</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Philip1"><label>12</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Philip</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Plantefeve</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Vuillaumier-Barrot</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Vicaut</surname><given-names>E</given-names></name>, <name name-style="western"><surname>LeMarie</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>1999</year>) <article-title>G894T polymorphism in the endothelial nitric oxide synthase gene is associated with an enhanced vascular responsiveness to phenylephrine</article-title>. <source>Circulation</source> <volume>99(24)</volume>: <fpage>3096</fpage>–<lpage>3098</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Angeline1"><label>13</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Angeline</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Isabel</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Tsongalis</surname><given-names>GJ</given-names></name> (<year>2010</year>) <article-title>Endothelial nitric oxide gene polymorphisms, nitric oxide production and coronary artery disease risk in a South Indian population</article-title>. <source>Exp Mol Pathol</source> <volume>89(3)</volume>: <fpage>205</fpage>–<lpage>208</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-BorKucukatay1"><label>14</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bor-Kucukatay</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Demir</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Akbay</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Dursunoglu</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Akdag</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Relationship between hemorheology and Glu(298)Asp polymorphism of endothelial nitric oxide synthase gene in patients with coronary artery disease</article-title>. <source>Mol Biol Rep</source> <volume>37(1)</volume>: <fpage>171</fpage>–<lpage>178</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Dafni1"><label>15</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dafni</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Drakoulis</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Landt</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Panidis</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Reczko</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Association of the eNOS E298D polymorphism and the risk of myocardial infarction in the Greek population</article-title>. <source>BMC Med Genet</source> <volume>11</volume>: <fpage>133</fpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Salimi1"><label>16</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Salimi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Firoozrai</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zand</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Nakhaee</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Shafiee</surname><given-names>SM</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Endothelial nitric oxide synthase gene Glu298Asp polymorphism in patients with coronary artery disease</article-title>. <source>Ann Saudi Med</source> <volume>30(1)</volume>: <fpage>33</fpage>–<lpage>37</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Salimi2"><label>17</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Salimi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Naghavi</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Firoozrai</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zand</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Tavilani</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Association of plasma nitric oxide concentration and endothelial nitric oxide synthase T-786C gene polymorphism in coronary artery disease</article-title>. <source>Pathophysiology</source> <volume>19(3)</volume>: <fpage>157</fpage>–<lpage>162</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Cai1"><label>18</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cai</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Wilcken</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>XL</given-names></name> (<year>1999</year>) <article-title>The Glu-298—&gt;Asp (894G—&gt;T) mutation at exon 7 of the endothelial nitric oxide synthase gene and coronary artery disease</article-title>. <source>J Mol Med (Berl)</source> <volume>77(6)</volume>: <fpage>511</fpage>–<lpage>514</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Nassar1"><label>19</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nassar</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Bevin</surname><given-names>LD</given-names></name>, <name name-style="western"><surname>Johnstone</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>O'Neill B</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Bata</surname><given-names>IR</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Relationship of the Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and early-onset coronary artery disease</article-title>. <source>Am Heart J</source> <volume>142(4)</volume>: <fpage>586</fpage>–<lpage>589</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Schmoelzer1"><label>20</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Schmoelzer</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Renner</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Paulweber</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Malaimare</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Iglseder</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>Lack of association of the Glu298Asp polymorphism of endothelial nitric oxide synthase with manifest coronary artery disease, carotid atherosclerosis and forearm vascular reactivity in two Austrian populations</article-title>. <source>Eur J Clin Invest</source> <volume>33(3)</volume>: <fpage>191</fpage>–<lpage>198</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Jaramillo1"><label>21</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jaramillo</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Munoz</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Lanas</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Lanas</surname><given-names>ZF</given-names></name>, <name name-style="western"><surname>Salazar</surname><given-names>LA</given-names></name> (<year>2006</year>) <article-title>Endothelial nitric oxide synthase G894T gene polymorphism in Chilean subjects with coronary artery disease and controls</article-title>. <source>Clin Chim Acta</source> <volume>371(1-2)</volume>: <fpage>102</fpage>–<lpage>106</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Kim1"><label>22</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kim</surname><given-names>IJ</given-names></name>, <name name-style="western"><surname>Bae</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Cha</surname><given-names>DH</given-names></name>, <name name-style="western"><surname>Cho</surname><given-names>HJ</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Influence of endothelial nitric oxide synthase gene polymorphisms (-786T&gt;C, 4a4b, 894G&gt;T) in Korean patients with coronary artery disease</article-title>. <source>Thromb Res</source> <volume>119(5)</volume>: <fpage>579</fpage>–<lpage>585</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Alp1"><label>23</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Alp</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Menevse</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Tulmac</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Kan</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Yalcin</surname><given-names>R</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Lack of association between matrix metalloproteinase-9 and endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in Turkish population</article-title>. <source>DNA Cell Biol</source> <volume>28(7)</volume>: <fpage>343</fpage>–<lpage>350</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Nakayama1"><label>24</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nakayama</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yasue</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Yoshimura</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Shimasaki</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Kugiyama</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>1999</year>) <article-title>T-786—&gt;C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm</article-title>. <source>Circulation</source> <volume>99(22)</volume>: <fpage>2864</fpage>–<lpage>2870</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Sandrim1"><label>25</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sandrim</surname><given-names>VC</given-names></name>, <name name-style="western"><surname>de Syllos</surname><given-names>RW</given-names></name>, <name name-style="western"><surname>Lisboa</surname><given-names>HR</given-names></name>, <name name-style="western"><surname>Tres</surname><given-names>GS</given-names></name>, <name name-style="western"><surname>Tanus-Santos</surname><given-names>JE</given-names></name> (<year>2006</year>) <article-title>Endothelial nitric oxide synthase haplotypes affect the susceptibility to hypertension in patients with type 2 diabetes mellitus</article-title>. <source>Atherosclerosis</source> <volume>189(1)</volume>: <fpage>241</fpage>–<lpage>246</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Miyamoto2"><label>26</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Miyamoto</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Saito</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Nakayama</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Shimasaki</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yoshimura</surname><given-names>T</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>Replication protein A1 reduces transcription of the endothelial nitric oxide synthase gene containing a -786T—&gt;C mutation associated with coronary spastic angina</article-title>. <source>Hum Mol Genet</source> <volume>9(18)</volume>: <fpage>2629</fpage>–<lpage>2637</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Alvarez1"><label>27</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Alvarez</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Gonzalez</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Batalla</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Reguero</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Iglesias-Cubero</surname><given-names>G</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Association between the NOS3 (-786 T/C) and the ACE (I/D) DNA genotypes and early coronary artery disease</article-title>. <source>Nitric Oxide</source> <volume>5(4)</volume>: <fpage>343</fpage>–<lpage>348</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Rios1"><label>28</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rios</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>Callegari-Jacques</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Hutz</surname><given-names>MH</given-names></name> (<year>2005</year>) <article-title>Endothelial nitric oxide synthase and fractalkine chemokine receptor polymorphisms on angiographically assessed coronary atherosclerosis</article-title>. <source>Clin Chim Acta</source> <volume>362(1-2)</volume>: <fpage>138</fpage>–<lpage>146</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Hyndman1"><label>29</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hyndman</surname><given-names>ME</given-names></name>, <name name-style="western"><surname>Parsons</surname><given-names>HG</given-names></name>, <name name-style="western"><surname>Verma</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Bridge</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Edworthy</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>The T-786—&gt;C mutation in endothelial nitric oxide synthase is associated with hypertension</article-title>. <source>Hypertension</source> <volume>39(4)</volume>: <fpage>919</fpage>–<lpage>922</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Rossi1"><label>30</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rossi</surname><given-names>GP</given-names></name>, <name name-style="western"><surname>Cesari</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Zanchetta</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Colonna</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Maiolino</surname><given-names>G</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>The T-786C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in Caucasian patients of the GENICA study</article-title>. <source>J Am Coll Cardiol</source> <volume>41(6)</volume>: <fpage>930</fpage>–<lpage>937</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Nakayama2"><label>31</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nakayama</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Yasue</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Yoshimura</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Shimasaki</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ogawa</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>T(-786)—&gt; C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with myocardial infarction, especially without coronary organic stenosis</article-title>. <source>Am J Cardiol</source> <volume>86(6)</volume>: <fpage>628</fpage>–<lpage>634</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Ragia1"><label>32</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ragia</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Nikolaidis</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Tavridou</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Arvanitidis</surname><given-names>KI</given-names></name>, <name name-style="western"><surname>Kanoni</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Endothelial nitric oxide synthase gene polymorphisms -786T&gt; C and 894G&gt; T in coronary artery bypass graft surgery patients</article-title>. <source>Hum Genomics</source> <volume>4(6)</volume>: <fpage>375</fpage>–<lpage>383</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Wang1"><label>33</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>XL</given-names></name>, <name name-style="western"><surname>Sim</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Badenhop</surname><given-names>RF</given-names></name>, <name name-style="western"><surname>McCredie</surname><given-names>RM</given-names></name>, <name name-style="western"><surname>Wilcken</surname><given-names>DE</given-names></name> (<year>1996</year>) <article-title>A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene</article-title>. <source>Nat Med</source> <volume>2(1)</volume>: <fpage>41</fpage>–<lpage>45</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Cine1"><label>34</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cine</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Hatemi</surname><given-names>AC</given-names></name>, <name name-style="western"><surname>Erginel-Unaltuna</surname><given-names>N</given-names></name> (<year>2002</year>) <article-title>Association of a polymorphism of the ecNOS gene with myocardial infarction in a subgroup of Turkish MI patients</article-title>. <source>Clin Genet</source> <volume>61(1)</volume>: <fpage>66</fpage>–<lpage>70</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Ichihara1"><label>35</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ichihara</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Yamada</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Fujimura</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Nakashima</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Yokota</surname><given-names>M</given-names></name> (<year>1998</year>) <article-title>Association of a polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infarction in the Japanese population</article-title>. <source>Am J Cardiol</source> <volume>81(1)</volume>: <fpage>83</fpage>–<lpage>86</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Park1"><label>36</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Park</surname><given-names>JE</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>WH</given-names></name>, <name name-style="western"><surname>Hwang</surname><given-names>TH</given-names></name>, <name name-style="western"><surname>Chu</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>Aging affects the association between endothelial nitric oxide synthase gene polymorphism and acute myocardial infarction in the Korean male population</article-title>. <source>Korean J Intern Med</source> <volume>15(1)</volume>: <fpage>65</fpage>–<lpage>70</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Granath1"><label>37</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Granath</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Taylor</surname><given-names>RR</given-names></name>, <name name-style="western"><surname>van Bockxmeer</surname><given-names>FM</given-names></name>, <name name-style="western"><surname>Mamotte</surname><given-names>CD</given-names></name> (<year>2001</year>) <article-title>Lack of evidence for association between endothelial nitric oxide synthase gene polymorphisms and coronary artery disease in the Australian Caucasian population</article-title>. <source>J Cardiovasc Risk</source> <volume>8(4)</volume>: <fpage>235</fpage>–<lpage>241</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Poirier1"><label>38</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Poirier</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Mao</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Mallet</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Nicaud</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Herrmann</surname><given-names>SM</given-names></name>, <etal>et al</etal>. (<year>1999</year>) <article-title>Polymorphisms of the endothelial nitric oxide synthase gene - no consistent association with myocardial infarction in the ECTIM study</article-title>. <source>Eur J Clin Invest</source> <volume>29(4)</volume>: <fpage>284</fpage>–<lpage>290</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Jaramillo2"><label>39</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jaramillo</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Lanas</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Lanas</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Salazar</surname><given-names>LA</given-names></name> (<year>2010</year>) <article-title>Polymorphisms of the NOS3 gene in Southern Chilean subjects with coronary artery disease and controls</article-title>. <source>Clin Chim Acta</source> <volume>411(3-4)</volume>: <fpage>258</fpage>–<lpage>262</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Li1"><label>40</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wu</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Feng</surname><given-names>G</given-names></name>, <name name-style="western"><surname>He</surname><given-names>L</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>The endothelial nitric oxide synthase gene is associated with coronary artery disease: a meta-analysis</article-title>. <source>Cardiology</source> <volume>116(4)</volume>: <fpage>271</fpage>–<lpage>278</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Zhang1"><label>41</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhang</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Bai</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Shi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>The G894T polymorphism on endothelial nitric oxide synthase gene is associated with increased coronary heart disease among Asia population: evidence from a Meta analysis</article-title>. <source>Thromb Res</source> <volume>130(2)</volume>: <fpage>192</fpage>–<lpage>197</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Liu1"><label>42</label>
<mixed-citation publication-type="other" xlink:type="simple">Liu D, Jiang Z, Dai L, Zhang X, Yan C, <etal>et al</etal>.. (2013) Association between the -786T&gt;C 1polymorphism in the promoter region of endothelial nitric oxide synthase (eNOS) and risk of coronary artery disease: A systematic review and meta-analysis. Gene pii: S0378-1119(13)01333-4.</mixed-citation>
</ref>
<ref id="pone.0113363-Tian1"><label>43</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tian</surname><given-names>GX</given-names></name>, <name name-style="western"><surname>Zeng</surname><given-names>XT</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>XB</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Association between the endothelial nitric oxide synthase gene Glu298Asp polymorphism and coronary heart disease: a metaanalysis of 39 casecontrol studies</article-title>. <source>Mol Med Rep</source> <volume>7(4)</volume>: <fpage>1310</fpage>–<lpage>1318</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Yang1"><label>44</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yang</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Du</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Lu</surname><given-names>X</given-names></name> (<year>2014</year>) <article-title>Endothelial nitric oxide synthase (eNOS) 4b/a gene polymorphisms and coronary artery disease: evidence from a meta-analysis</article-title>. <source>Int J Mol Sci</source> <volume>15(5)</volume>: <fpage> 7987</fpage>–<lpage>8003</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Panic1"><label>45</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Panic</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Leoncini</surname><given-names>E</given-names></name>, <name name-style="western"><surname>de Belvis</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Ricciardi</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Boccia</surname><given-names>S</given-names></name> (<year>2013</year>) <article-title>Evaluation of the endorsement of the preferred reporting items for systematic reviews and meta-analysis (PRISMA) statement on the quality of published systematic review and meta-analyses</article-title>. <source>PLoS One</source> <volume>8(12)</volume>: <fpage>e83138</fpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Lewis1"><label>46</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lewis</surname><given-names>CM</given-names></name> (<year>2002</year>) <article-title>Genetic association studies: design, analysis and interpretation</article-title>. <source>Brief Bioinform</source> <volume>3(2)</volume>: <fpage>146</fpage>–<lpage>153</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-DerSimonian1"><label>47</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DerSimonian</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Laird</surname><given-names>N</given-names></name> (<year>1986</year>) <article-title>Meta-analysis in clinical trials</article-title>. <source>Control Clin Trials</source> <volume>7(3)</volume>: <fpage>177</fpage>–<lpage>188</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Mantel1"><label>48</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mantel</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Haenszel</surname><given-names>W</given-names></name> (<year>1959</year>) <article-title>Statistical aspects of the analysis of data from retrospective studies of disease</article-title>. <source>J Natl Cancer Inst</source> <volume>22(4)</volume>: <fpage>719</fpage>–<lpage>748</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Higgins1"><label>49</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Deeks</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Altman</surname><given-names>DG</given-names></name> (<year>2003</year>) <article-title>Measuring inconsistency in meta-analyses</article-title>. <source>Bmj</source> <volume>327(7414)</volume>: <fpage>557</fpage>–<lpage>560</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Begg1"><label>50</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begg</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname><given-names>M</given-names></name> (<year>1994</year>) <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biometrics</source> <volume>50(4)</volume>: <fpage>1088</fpage>–<lpage>1101</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Egger1"><label>51</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Davey Smith</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Schneider</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Minder</surname><given-names>C</given-names></name> (<year>1997</year>) <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>Bmj</source> <volume>315(7109)</volume>: <fpage>629</fpage>–<lpage>634</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Clayton1"><label>52</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Clayton</surname><given-names>D</given-names></name>, <name name-style="western"><surname>McKeigue</surname><given-names>PM</given-names></name> (<year>2001</year>) <article-title>Epidemiological methods for studying genes and environmental factors in complex diseases</article-title>. <source>The Lancet</source> <volume>358(9290)</volume>: <fpage> 1356</fpage>–<lpage>1360</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Pulkkinen1"><label>53</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pulkkinen</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Viitanen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Kareinen</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lehto</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Vauhkonen</surname><given-names>I</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with elevated blood pressure in type 2 diabetic patients with coronary heart disease</article-title>. <source>J Mol Med (Berl)</source> <volume>78(7)</volume>: <fpage>372</fpage>–<lpage>379</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Agema1"><label>54</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Agema</surname><given-names>WR</given-names></name>, <name name-style="western"><surname>de Maat</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Zwinderman</surname><given-names>AH</given-names></name>, <name name-style="western"><surname>Kastelein</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Rabelink</surname><given-names>TJ</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>An integrated evaluation of endothelial constitutive nitric oxide synthase polymorphisms and coronary artery disease in men</article-title>. <source>Clin Sci (Lond)</source> <volume>107(3)</volume>: <fpage>255</fpage>–<lpage>261</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Fatini1"><label>55</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fatini</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Sofi</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Sticchi</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Gensini</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Gori</surname><given-names>AM</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Influence of endothelial nitric oxide synthase gene polymorphisms (G894T, 4a4b, T-786C) and hyperhomocysteinemia on the predisposition to acute coronary syndromes</article-title>. <source>Am Heart J</source>.<volume>147</volume><supplement>(3)</supplement>: <fpage>516</fpage>–<lpage>521</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Antoniades1"><label>56</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Antoniades</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Tousoulis</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Vasiliadou</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Pitsavos</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Chrysochoou</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Genetic polymorphism on endothelial nitric oxide synthase affects endothelial activation and inflammatory response during the acute phase of myocardial infarction</article-title>. <source>J Am Coll Cardiol</source>.<volume>46</volume><supplement>(6)</supplement>: <fpage>1101</fpage>–<lpage>1109</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Rios2"><label>57</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rios</surname><given-names>DL</given-names></name>, <name name-style="western"><surname>D'Onofrio</surname><given-names>LO</given-names></name>, <name name-style="western"><surname>Souza</surname><given-names>JK</given-names></name>, <name name-style="western"><surname>Queiroz</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Raduy-Maron</surname><given-names>L</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Smoking-dependent and haplotype-specific effects of endothelial nitric oxide synthase gene polymorphisms on angiographically assessed coronary artery disease in Caucasian- and African-Brazilians</article-title>. <source>Atherosclerosis</source> <volume>193(1)</volume>: <fpage> 135</fpage>–<lpage>41</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Sampaio1"><label>58</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sampaio</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Hirata</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Hirata</surname><given-names>RD</given-names></name>, <name name-style="western"><surname>Santos</surname><given-names>FC</given-names></name>, <name name-style="western"><surname>Picciotti</surname><given-names>R</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>AMI is associated with polymorphisms in the NOS3 and FGB but not in PAI-1 genes in young adults</article-title>. <source>Clin Chim Acta</source> <volume>377(1-2)</volume>: <fpage>154</fpage>–<lpage>162</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Andrikopoulos1"><label>59</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Andrikopoulos</surname><given-names>GK</given-names></name>, <name name-style="western"><surname>Grammatopoulos</surname><given-names>DK</given-names></name>, <name name-style="western"><surname>Tzeis</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Zervou</surname><given-names>SI</given-names></name>, <name name-style="western"><surname>Richter</surname><given-names>DJ</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Association of the 894G&gt;T polymorphism in the endothelial nitric oxide synthase gene with risk of acute myocardial infarction</article-title>. <source>BMC Med Genet</source> <volume>9</volume>: <fpage>43</fpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Szperl1"><label>60</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Szperl</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Dzielinska</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Roszczynko</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Malek</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Makowiecka-Ciesla</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Genetic variants in hypertensive patients with coronary artery disease and coexisting atheromatous renal artery stenosis</article-title>. <source>Med Sci Monit</source> <volume>14(12)</volume>: <fpage>Cr611</fpage>–<lpage>616</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Vasilakou1"><label>61</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vasilakou</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Votteas</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Kasparian</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Pantazopoulos</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Dedoussis</surname><given-names>G</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Lack of association between endothelial nitric oxide synthase gene polymorphisms and risk of premature coronary artery disease in the Greek population</article-title>. <source>Acta Cardiol</source> <volume>63(5)</volume>: <fpage>609</fpage>–<lpage>614</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Gluba1"><label>62</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gluba</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Banach</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Rysz</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Piotrowski</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Fendler</surname><given-names>W</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Is polymorphism within eNOS gene associated with the late onset of myocardial infarction? A pilot study</article-title>. <source>Angiology</source> <volume>60(5)</volume>: <fpage>588</fpage>–<lpage>595</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-IsordiaSalas1"><label>63</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Isordia-Salas</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Leanos-Miranda</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Borrayo-Sanchez</surname><given-names>G</given-names></name> (<year>2010</year>) <article-title>The Glu298Asp polymorphism of the endothelial nitric oxide synthase gene is associated with premature ST elevation myocardial infarction in Mexican population</article-title>. <source>Clin Chim Acta</source> <volume>411(7-8)</volume>: <fpage>553</fpage>–<lpage>557</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-daCostaEscobarPiccoli1"><label>64</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>da Costa Escobar Piccoli</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Manfredini</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Hamester</surname><given-names>FI</given-names></name>, <name name-style="western"><surname>Bandinelli</surname><given-names>JB</given-names></name>, <name name-style="western"><surname>Turkienicz</surname><given-names>IM</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Interaction between endothelial nitric oxide synthase gene polymorphisms (-786T&gt;C, 894G&gt;T and intron 4 a/b) and cardiovascular risk factors in acute coronary syndromes</article-title>. <source>Arch Med Res</source> <volume>43(3)</volume>: <fpage> 205</fpage>–<lpage>11</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Zigra1"><label>65</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zigra</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Rallidis</surname><given-names>LS</given-names></name>, <name name-style="western"><surname>Anastasiou</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Merkouri</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Gialeraki</surname><given-names>A</given-names></name> (<year>2013</year>) <article-title>eNOS gene variants and the risk of premature myocardial infarction</article-title>. <source>Dis Markers</source> <volume>34(6)</volume>: <fpage>431</fpage>–<lpage>436</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Aras1"><label>66</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Aras</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Hanson</surname><given-names>NQ</given-names></name>, <name name-style="western"><surname>Bakanay</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Tsai</surname><given-names>MY</given-names></name>, <name name-style="western"><surname>Gulec</surname><given-names>S</given-names></name> (<year>2002</year>) <article-title>Endothelial nitric oxide gene polymorphism (Glu298Asp) is not associated with coronary artery disease in Turkish population</article-title>. <source>Thromb Haemost</source> <volume>87(2)</volume>: <fpage>347</fpage>–<lpage>349</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Afrasyap1"><label>67</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Afrasyap</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Ozturk</surname><given-names>G</given-names></name> (<year>2004</year>) <article-title>NO level and endothelial NO synthase gene polymorphism (Glu298Asp) in the patients with coronary artery disease from the Turkish population</article-title>. <source>Acta Biochim Biophys Sin (Shanghai)</source> <volume>36(10)</volume>: <fpage>661</fpage>–<lpage>666</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Berdeli1"><label>68</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Berdeli</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sekuri</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Sirri Cam</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Ercan</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Sagcan</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Association between the eNOS (Glu298Asp) and the RAS genes polymorphisms and premature coronary artery disease in a Turkish population</article-title>. <source>Clin Chim Acta</source> <volume>351(1-2)</volume>: <fpage>87</fpage>–<lpage>94</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Cam1"><label>69</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cam</surname><given-names>SF</given-names></name>, <name name-style="western"><surname>Sekuri</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Tengiz</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Ercan</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Sagcan</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>The G894T polymorphism on endothelial nitric oxide synthase gene is associated with premature coronary artery disease in a Turkish population</article-title>. <source>Thromb Res</source> <volume>116(4)</volume>: <fpage>287</fpage>–<lpage>292</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Kerkeni1"><label>70</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kerkeni</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Addad</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Chauffert</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Myara</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ben Farhat</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Hyperhomocysteinemia, endothelial nitric oxide synthase polymorphism, and risk of coronary artery disease</article-title>. <source>Clin Chem</source> <volume>52(1)</volume>: <fpage>53</fpage>–<lpage>58</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Alkharfy1"><label>71</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Alkharfy</surname><given-names>KM</given-names></name>, <name name-style="western"><surname>Al-Daghri</surname><given-names>NM</given-names></name>, <name name-style="western"><surname>Al-Attas</surname><given-names>OS</given-names></name>, <name name-style="western"><surname>Alokail</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Draz</surname><given-names>HM</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Endothelial nitric oxide synthase gene polymorphisms (894G&gt; T and -786T&gt; C) and risk of coronary artery disease in a Saudi population</article-title>. <source>Arch Med Res</source> <volume>41(2)</volume>: <fpage>134</fpage>–<lpage>141</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Motawi1"><label>72</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Motawi</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Shaker</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Taha</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sedrak</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Nabil</surname><given-names>M</given-names></name> (<year>2011</year>) <article-title>Endothelial nitric oxide synthase and angiotensinogen gene polymorphism in coronary artery diseases in Egypt</article-title>. <source>Angiology</source> <volume>62(2)</volume>: <fpage>191</fpage>–<lpage>7</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Gad1"><label>73</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gad</surname><given-names>MZ</given-names></name>, <name name-style="western"><surname>Abdel Rahman</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Hashad</surname><given-names>IM</given-names></name>, <name name-style="western"><surname>Abdel-Maksoud</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Farag</surname><given-names>NM</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Endothelial nitric oxide synthase (G894T) gene polymorphism in a random sample of the Egyptian population: comparison with myocardial infarction patients</article-title>. <source>Genet Test Mol Biomarkers</source> <volume>16(7)</volume>: <fpage>695</fpage>–<lpage>700</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Rahimi1"><label>74</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rahimi</surname><given-names>Z</given-names></name>, <name name-style="western"><surname>Nourozi-Rad</surname><given-names>R</given-names></name> (<year>2012</year>) <article-title>Association of endothelial nitric oxide synthase gene variant (G894T) with coronary artery disease in Western Iran</article-title>. <source>Angiology</source> <volume>63(2)</volume>: <fpage>131</fpage>–<lpage>137</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-AbdelAziz1"><label>75</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Abdel-Aziz</surname><given-names>TA</given-names></name>, <name name-style="western"><surname>Mohamed</surname><given-names>RH</given-names></name> (<year>2013</year>) <article-title>Association of endothelial nitric oxide synthase gene polymorphisms with classical risk factors in development of premature coronary artery disease</article-title>. <source>Mol Biol Rep</source> <volume>40(4)</volume>: <fpage>3065</fpage>–<lpage>3071</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Kallel1"><label>76</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kallel</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Sbai</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Sediri</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Abdessalem</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Mourali</surname><given-names>MS</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>Polymorphisms of the NOS3 gene and risk of myocardial infarction in the Tunisian population</article-title>. <source>Cytokine</source> <volume>64(3)</volume>: <fpage>646</fpage>–<lpage>651</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Yoon1"><label>77</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yoon</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Song</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Hong</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>JQ</given-names></name> (<year>2000</year>) <article-title>Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease</article-title>. <source>Clin Chem</source> <volume>46(10)</volume>: <fpage>1626</fpage>–<lpage>1630</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Wang2"><label>78</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>CL</given-names></name>, <name name-style="western"><surname>Hsu</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Ko</surname><given-names>YS</given-names></name>, <name name-style="western"><surname>Ko</surname><given-names>YL</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>YH</given-names></name> (<year>2001</year>) <article-title>Lack of association between the Glu298Asp variant of the endothelial nitric oxide synthase gene and the risk of coronary artery disease among Taiwanese</article-title>. <source>J Formos Med Assoc</source> <volume>100(11)</volume>: <fpage>736</fpage>–<lpage>740</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Jo1"><label>79</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jo</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Moon</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Yoon</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>HT</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Interaction between -786TC polymorphism in the endothelial nitric oxide synthase gene and smoking for myocardial infarction in Korean population</article-title>. <source>Clin Chim Acta</source> <volume>365(1-2)</volume>: <fpage>86</fpage>–<lpage>92</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Lin1"><label>80</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lin</surname><given-names>NT</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>RP</given-names></name>, <name name-style="western"><surname>Hong</surname><given-names>AI</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>HI</given-names></name> (<year>2008</year>) <article-title>Analysis of endothelial nitric oxide synthase gene polymorphisms with cardiovascular diseases in eastern Taiwan</article-title>. <source>Chin J Physiol</source> <volume>51(1)</volume>: <fpage>42</fpage>–<lpage>47</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Tamemoto1"><label>81</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tamemoto</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ishikawa</surname><given-names>SE</given-names></name>, <name name-style="western"><surname>Kawakami</surname><given-names>M</given-names></name> (<year>2008</year>) <article-title>Association of the Glu298Asp polymorphism of the eNOS Gene with ischemic heart disease in Japanese diabetic subjects</article-title>. <source>Diabetes Res Clin Pract</source> <volume>80(2)</volume>: <fpage>275</fpage>–<lpage>279</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Bae1"><label>82</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bae</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>IJ</given-names></name>, <name name-style="western"><surname>Hong</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Sung</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Lim</surname><given-names>SW</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>Association of endothelial nitric oxide synthase polymorphisms with coronary artery disease in Korean individuals with or without diabetes mellitus</article-title>. <source>Exp Ther Med</source> <volume>1(4)</volume>: <fpage>719</fpage>–<lpage>724</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Min1"><label>83</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Min</surname><given-names>BW</given-names></name>, <name name-style="western"><surname>Na</surname><given-names>JY</given-names></name>, <name name-style="western"><surname>Juhng</surname><given-names>SW</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Park</surname><given-names>JT</given-names></name>, <etal>et al</etal>. (<year>2010</year>) <article-title>A polymorphism (G894T) in eNOS increases the risk of coronary atherosclerosis rather than intracranial atherosclerosis in Koreans</article-title>. <source>Acta Neurol Belg</source> <volume>110(3)</volume>: <fpage>255</fpage>–<lpage>262</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Mathew1"><label>84</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Mathew</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Narayanan</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Sundaram</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Jayaraman</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Dutta</surname><given-names>TK</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Lack of association between Glu(298) asp polymorphism of endothelial nitric oxide synthase (eNOS) gene and coronary artery disease in Tamilian population</article-title>. <source>Indian Heart J</source> <volume>60(3)</volume>: <fpage>223</fpage>–<lpage>227</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Bhanushali1"><label>85</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bhanushali</surname><given-names>AA</given-names></name>, <name name-style="western"><surname>Das</surname><given-names>BR</given-names></name> (<year>2010</year>) <article-title>Genetic variants at the APOE, lipoprotein lipase (LpL), cholesteryl ester transfer protein (CETP), and endothelial nitric oxide (eNOS) genes and coronary artery disease (CAD): CETP Taq1 B2B2 associates with lower risk of CAD in Asian Indians</article-title>. <source>J Community Genet</source> <volume>1(2)</volume>: <fpage>55</fpage>–<lpage>62</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Saini1"><label>86</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Saini</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Bhatnagar</surname><given-names>MK</given-names></name>, <name name-style="western"><surname>Bhattacharjee</surname><given-names>J</given-names></name> (<year>2011</year>) <article-title>Association of endothelial dysfunction with endothelin, nitric oxide and eNOS Glu298Asp gene polymorphism in coronary artery disease</article-title>. <source>Dis Markers</source> <volume>31(4)</volume>: <fpage> 215</fpage>–<lpage>22</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Rai1"><label>87</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rai</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Fitt</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Sharma</surname><given-names>AK</given-names></name>, <name name-style="western"><surname>Sinha</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Kumar</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2012</year>) <article-title>Lack of association between Glu298Asp polymorphism and coronary artery disease in North Indians</article-title>. <source>Mol Biol Rep</source> <volume>39(5)</volume>: <fpage>5995</fpage>–<lpage>6000</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Saini2"><label>88</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Saini</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Bhatnagar</surname><given-names>MK</given-names></name>, <name name-style="western"><surname>Bhattacharjee</surname><given-names>J</given-names></name> (<year>2012</year>) <article-title>Endothelial nitric oxide synthase Glu298Asp (G894T) gene polymorphism in coronary artery disease patients with type 2 diabetes mellitus</article-title>. <source>Diabetes Metab Syndr</source> <volume>6(2)</volume>: <fpage> 106</fpage>–<lpage>9</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-ArunKumar1"><label>89</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Arun Kumar</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Umamaheswaran</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Padmapriya</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Balachandar</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Adithan</surname><given-names>C</given-names></name> (<year>2013</year>) <article-title>Endothelial nitric oxide synthase gene polymorphisms and the risk of acute myocardial infarction in a South Indian population</article-title>. <source>Mol Biol Rep</source> <volume>40(2)</volume>: <fpage> 1275</fpage>–<lpage>81</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Narne1"><label>90</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Narne</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Ponnaluri</surname><given-names>KC</given-names></name>, <name name-style="western"><surname>Singh</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Siraj</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Ishaq</surname><given-names>M</given-names></name> (<year>2013</year>) <article-title>Association of the genetic variants of endothelial nitric oxide synthase gene with angiographically defined coronary artery disease and myocardial infarction in South Indian patients with type 2 diabetes mellitus</article-title>. <source>J Diabetes Complications</source> <volume>27(3)</volume>: <fpage>255</fpage>–<lpage>261</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Dosenko1"><label>91</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dosenko</surname><given-names>VE</given-names></name>, <name name-style="western"><surname>Zagoriy</surname><given-names>VY</given-names></name>, <name name-style="western"><surname>Lutay</surname><given-names>YM</given-names></name>, <name name-style="western"><surname>Parkhomenko</surname><given-names>AN</given-names></name>, <name name-style="western"><surname>Moibenko</surname><given-names>AA</given-names></name> (<year>2006</year>) <article-title>Allelic polymorphism in the promoter (T—&gt;C), but not in exon 7 (G—&gt;T) or the variable number tandem repeat in intron 4, of the endothelial nitric oxide synthase gene is positively associated with acute coronary syndrome in the Ukrainian population</article-title>. <source>Exp Clin Cardiol</source> <volume>11(1)</volume>: <fpage>11</fpage>–<lpage>13</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Jaramillo3"><label>92</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jaramillo</surname><given-names>PC</given-names></name>, <name name-style="western"><surname>Lanas</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Lanas</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Salazar</surname><given-names>LA</given-names></name> (<year>2008</year>) <article-title>-786T&gt;C polymorphism of the endothelial nitric oxide synthase gene in Chilean subjects with coronary artery disease and controls</article-title>. <source>Clin Chim Acta</source> <volume>387(1-2)</volume>: <fpage>105</fpage>–<lpage>108</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Meluzin1"><label>93</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Meluzin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Vasku</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Kincl</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Panovsky</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Sramkova</surname><given-names>T</given-names></name> (<year>2009</year>) <article-title>Association of coronary artery disease, erectile dysfunction, and endothelial nitric oxide synthase polymorphisms</article-title>. <source>Heart Vessels</source> <volume>24(3)</volume>: <fpage>157</fpage>–<lpage>163</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Tangurek1"><label>94</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tangurek</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Ozer</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Sayar</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Terzi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Yilmaz</surname><given-names>H</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>The relationship between endothelial nitric oxide synthase gene polymorphism (T-786 C) and coronary artery disease in the Turkish population</article-title>. <source>Heart Vessels</source> <volume>21(5)</volume>: <fpage>285</fpage>–<lpage>290</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Ciftci1"><label>95</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ciftci</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Melil</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Cebi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Ersoz</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cagatay</surname><given-names>P</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Association of endothelial nitric oxide synthase promoter region (T-786C) gene polymorphism with acute coronary syndrome and coronary heart disease</article-title>. <source>Lipids Health Dis</source> <volume>7</volume>: <fpage>5</fpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Takagi1"><label>96</label>
<mixed-citation publication-type="other" xlink:type="simple">Takagi S, Goto Y, Nonogi H, Baba S, Iwai N (2001) Genetic polymorphisms of angiotensin converting enzyme (I/D) and endothelial nitric oxide synthase (T(-788)C) genes in Japanese patients with myocardial infarction. Thromb Haemost Germany p. 1339–40.</mixed-citation>
</ref>
<ref id="pone.0113363-Han1"><label>97</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Han</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Ji</surname><given-names>Y</given-names></name> (<year>2010</year>) <article-title>T-786C polymorphism in the endothelial nitric oxide synthase gene is associated with increased risk of coronary artery disease in a Chinese population</article-title>. <source>Pharmacology</source> <volume>85(4)</volume>: <fpage>211</fpage>–<lpage>216</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Hooper1"><label>98</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hooper</surname><given-names>WC</given-names></name>, <name name-style="western"><surname>Lally</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Austin</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Benson</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Dilley</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>1999</year>) <article-title>The relationship between polymorphisms in the endothelial cell nitric oxide synthase gene and the platelet GPIIIa gene with myocardial infarction and venous thromboembolism in African Americans</article-title>. <source>Chest</source> <volume>116(4)</volume>: <fpage> 880</fpage>–<lpage>6</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Fowkes1"><label>99</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fowkes</surname><given-names>FG</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>AJ</given-names></name>, <name name-style="western"><surname>Hau</surname><given-names>CM</given-names></name>, <name name-style="western"><surname>Cooke</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Connor</surname><given-names>JM</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>Methylene tetrahydrofolate reductase (MTHFR) and nitric oxide synthase (ecNOS) genes and risks of peripheral arterial disease and coronary heart disease: Edinburgh Artery Study</article-title>. <source>Atherosclerosis</source> <volume>150(1)</volume>: <fpage>179</fpage>–<lpage>185</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Pulkkinen2"><label>100</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pulkkinen</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Viitanen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Kareinen</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lehto</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Vauhkonen</surname><given-names>I</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>Intron 4 polymorphism of the endothelial nitric oxide synthase gene is associated with elevated blood pressure in type 2 diabetic patients with coronary heart disease</article-title>. <source>J Mol Med (Berl)</source> <volume>78(7)</volume>: <fpage>372</fpage>–<lpage>379</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Sigusch1"><label>101</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sigusch</surname><given-names>HH</given-names></name>, <name name-style="western"><surname>Surber</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Lehmann</surname><given-names>MH</given-names></name>, <name name-style="western"><surname>Surber</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Weber</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>Lack of association between 27-bp repeat polymorphism in intron 4 of the endothelial nitric oxide synthase gene and the risk of coronary artery disease</article-title>. <source>Scand J Clin Lab Invest</source> <volume>60(3)</volume>: <fpage>229</fpage>–<lpage>235</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Letonja1"><label>102</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Letonja</surname><given-names>M</given-names></name> (<year>2004</year>) <article-title>The eNOS gene polymorphism does not have a major impact on lipid parameters and premature coronary artery disease in Caucasian women</article-title>. <source>Acta Cardiol</source> <volume>59(6)</volume>: <fpage>618</fpage>–<lpage>622</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Milutinovic1"><label>103</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Milutinovic</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hruskovicova</surname><given-names>H</given-names></name> (<year>2005</year>) <article-title>The eNOS gene polymorphism does not have a major impact on lipid parameters and premature coronary artery disease in Slovene men (Caucasians)</article-title>. <source>Folia Biol (Praha)</source> <volume>51(2)</volume>: <fpage>47</fpage>–<lpage>49</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Rao1"><label>104</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rao</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Austin</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Davidoff</surname><given-names>MN</given-names></name>, <name name-style="western"><surname>Zafari</surname><given-names>AM</given-names></name> (<year>2005</year>) <article-title>Endothelial nitric oxide synthase intron 4 polymorphism is a marker for coronary artery disease in African-American and Caucasian men</article-title>. <source>Ethn Dis</source> <volume>15(2)</volume>: <fpage> 191</fpage>–<lpage>7</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Kincl1"><label>105</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kincl</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Vasku</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Meluzin</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Panovsky</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Semenka</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Association of the eNOS 4a/b and -786T/C polymormphisms with coronary artery disease, obesity and diabetes mellitus</article-title>. <source>Folia Biol (Praha)</source> <volume>55(5)</volume>: <fpage>187</fpage>–<lpage>191</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Matyar1"><label>106</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Matyar</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Attila</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Acarturk</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Akpinar</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Inal</surname><given-names>T</given-names></name> (<year>2005</year>) <article-title>eNOS gene intron 4 a/b VNTR polymorphism is a risk factor for coronary artery disease in Southern Turkey</article-title>. <source>Clin Chim Acta</source> <volume>354(1-2)</volume>: <fpage>153</fpage>–<lpage>158</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Agirbasli1"><label>107</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Agirbasli</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Agirbasli</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>SM</given-names></name>, <name name-style="western"><surname>Phillips</surname><given-names>JA</given-names><suffix>3rd</suffix></name> (<year>2006</year>) <article-title>Interaction among 5,10 methylenetetrahydrofolate reductase, plasminogen activator inhibitor and endothelial nitric oxide synthase gene polymorphisms predicts the severity of coronary artery disease in Turkish patients</article-title>. <source>Coron Artery Dis</source> <volume>17(5)</volume>: <fpage>413</fpage>–<lpage>417</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Agirbasli2"><label>108</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Agirbasli</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Guney</surname><given-names>AI</given-names></name>, <name name-style="western"><surname>Ozturhan</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>Agirbasli</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ulucan</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Multifactor dimensionality reduction analysis of MTHFR, PAI-1, ACE, PON1, and eNOS gene polymorphisms in patients with early onset coronary artery disease</article-title>. <source>Eur J Cardiovasc Prev Rehabil</source> <volume>18(6)</volume>: <fpage>803</fpage>–<lpage>809</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Salimi3"><label>109</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Salimi</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Firoozrai</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Nourmohammadi</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Shabani</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Mohebbi</surname><given-names>A</given-names></name> (<year>2006</year>) <article-title>Endothelial nitric oxide synthase gene intron4 VNTR polymorphism in patients with coronary artery disease in Iran</article-title>. <source>Indian J Med Res</source> <volume>124(6)</volume>: <fpage>683</fpage>–<lpage>688</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Jemaa1"><label>110</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jemaa</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Kallel</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ben Ali</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Omar</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Chabrak</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Association of a 27-bp repeat polymorphism in intron 4 of endothelial constitutive nitric oxide synthase gene with myocardial infarction in Tunisian patients</article-title>. <source>Clin Chem Lab Med</source> <volume>45(11)</volume>: <fpage> 1476</fpage>–<lpage>80</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Ekmekci1"><label>111</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ekmekci</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Ozcan</surname><given-names>KS</given-names></name>, <name name-style="western"><surname>Gungor</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Abaci</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Osmonov</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2013</year>) <article-title>The relationship between endothelial nitric oxide synthase 4a/4b gene polymorphism and premature coronary artery disease</article-title>. <source>Acta Cardiol</source> <volume>68(5)</volume>: <fpage>464</fpage>–<lpage>468</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Odawara1"><label>112</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Odawara</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Sasaki</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Tachi</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yamashita</surname><given-names>K</given-names></name> (<year>1998</year>) <article-title>Endothelial nitric oxide synthase gene polymorphism and coronary heart disease in Japanese NIDDM</article-title>. <source>Diabetologia</source> <volume>41(3)</volume>: <fpage>365</fpage>–<lpage>366</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Nakagami1"><label>113</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nakagami</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Ikeda</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Maeda</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Yamamoto</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Hojo</surname><given-names>Y</given-names></name>, <etal>et al</etal>. (<year>1999</year>) <article-title>Coronary artery disease and endothelial nitric oxide synthase and angiotensin-converting enzyme gene polymorphisms</article-title>. <source>J Thromb Thrombolysis</source> <volume>8(3)</volume>: <fpage> 191</fpage>–<lpage>5</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Lee1"><label>114</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname><given-names>WH</given-names></name>, <name name-style="western"><surname>Hwang</surname><given-names>TH</given-names></name>, <name name-style="western"><surname>Oh</surname><given-names>GT</given-names></name>, <name name-style="western"><surname>Kwon</surname><given-names>SU</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>YH</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Genetic factors associated with endothelial dysfunction affect the early onset of coronary artery disease in Korean males</article-title>. <source>Vasc Med</source> <volume>6(2)</volume>: <fpage>103</fpage>–<lpage>108</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Hwang1"><label>115</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hwang</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Tsai</surname><given-names>CT</given-names></name>, <name name-style="western"><surname>Yeh</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Chiang</surname><given-names>FT</given-names></name>, <name name-style="western"><surname>Hsu</surname><given-names>KL</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>The 27-bp tandem repeat polymorphism in intron 4 of the endothelial nitric oxide synthase gene is not associated with coronary artery disease in a hospital-based Taiwanese population</article-title>. <source>Cardiology</source> <volume>97(2)</volume>: <fpage> 67</fpage>–<lpage>72</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Gururajan1"><label>116</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gururajan</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Gurumurthy</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Victor</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Srinivasa Nageswara Rao</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Sai Babu</surname><given-names>R</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Plasma total nitric oxide and endothelial constitutive nitric oxide synthase (ecNOS) gene polymorphism: a study in a South Indian population</article-title>. <source>Biochem Genet</source> <volume>49(1-2)</volume>: <fpage> 96</fpage>–<lpage>103</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Salom1"><label>117</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Salom</surname><given-names>MG</given-names></name>, <name name-style="western"><surname>Arregui</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Carbonell</surname><given-names>LF</given-names></name>, <name name-style="western"><surname>Ruiz</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Gonzalez-Mora</surname><given-names>JL</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Renal ischemia induces an increase in nitric oxide levels from tissue stores</article-title>. <source>Am J Physiol Regul Integr Comp Physiol</source> <volume>289(5)</volume>: <fpage>R1459</fpage>–<lpage>1466</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Kelm1"><label>118</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kelm</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Feelisch</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Deussen</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Strauer</surname><given-names>BE</given-names></name>, <name name-style="western"><surname>Schrader</surname><given-names>J</given-names></name> (<year>1991</year>) <article-title>Release of endothelium derived nitric oxide in relation to pressure and flow</article-title>. <source>Cardiovasc Res</source> <volume>25(10)</volume>: <fpage>831</fpage>–<lpage>836</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Tesauro1"><label>119</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tesauro</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>WC</given-names></name>, <name name-style="western"><surname>Rogliani</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Qi</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Chaudhary</surname><given-names>PP</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>97(6)</volume>: <fpage>2832</fpage>–<lpage>2835</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Persu1"><label>120</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Persu</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Stoenoiu</surname><given-names>MS</given-names></name>, <name name-style="western"><surname>Messiaen</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Davila</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Robino</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Modifier effect of ENOS in autosomal dominant polycystic kidney disease. Hum Mol Genet</article-title>. <volume>11(3)</volume>: <fpage>229</fpage>–<lpage>241</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Rankinen1"><label>121</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rankinen</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Rice</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Perusse</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Chagnon</surname><given-names>YC</given-names></name>, <name name-style="western"><surname>Gagnon</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>NOS3 Glu298Asp genotype and blood pressure response to endurance training: the HERITAGE family study</article-title>. <source>Hypertension</source> <volume>36(5)</volume>: <fpage>885</fpage>–<lpage>889</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Naber1"><label>122</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Naber</surname><given-names>CK</given-names></name>, <name name-style="western"><surname>Baumgart</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Altmann</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Siffert</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Erbel</surname><given-names>R</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>eNOS 894T allele and coronary blood flow at rest and during adenosine-induced hyperemia</article-title>. <source>Am J Physiol Heart Circ Physiol</source> <volume>281(5)</volume>: <fpage>H1908</fpage>–<lpage>1912</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Savvidou1"><label>123</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Savvidou</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Vallance</surname><given-names>PJ</given-names></name>, <name name-style="western"><surname>Nicolaides</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Hingorani</surname><given-names>AD</given-names></name> (<year>2001</year>) <article-title>Endothelial nitric oxide synthase gene polymorphism and maternal vascular adaptation to pregnancy</article-title>. <source>Hypertension</source> <volume>38(6)</volume>: <fpage>1289</fpage>–<lpage>1293</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Jeerooburkhan1"><label>124</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jeerooburkhan</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Jones</surname><given-names>LC</given-names></name>, <name name-style="western"><surname>Bujac</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Cooper</surname><given-names>JA</given-names></name>, <name name-style="western"><surname>Miller</surname><given-names>GJ</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Genetic and environmental determinants of plasma nitrogen oxides and risk of ischemic heart disease</article-title>. <source>Hypertension</source> <volume>38(5)</volume>: <fpage>1054</fpage>–<lpage>1061</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Tsukada1"><label>125</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tsukada</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Yokoyama</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Arai</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Takemoto</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Hara</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>1998</year>) <article-title>Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans</article-title>. <source>Biochem Biophys Res Commun</source> <volume>245(1)</volume>: <fpage>190</fpage>–<lpage>193</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Wang3"><label>126</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>XL</given-names></name>, <name name-style="western"><surname>Sim</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>MX</given-names></name>, <name name-style="western"><surname>Murrell</surname><given-names>GA</given-names></name>, <name name-style="western"><surname>Trudinger</surname><given-names>B</given-names></name>, <etal>et al</etal>. (<year>2000</year>) <article-title>Genotype dependent and cigarette specific effects on endothelial nitric oxide synthase gene expression and enzyme activity</article-title>. <source>FEBS Lett</source> <volume>471(1)</volume>: <fpage>45</fpage>–<lpage>50</lpage>.</mixed-citation>
</ref>
<ref id="pone.0113363-Wang4"><label>127</label>
<mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wang</surname><given-names>XL</given-names></name>, <name name-style="western"><surname>Mahaney</surname><given-names>MC</given-names></name>, <name name-style="western"><surname>Sim</surname><given-names>AS</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Wang</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>1997</year>) <article-title>Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels</article-title>. <source>Arterioscler Thromb Vasc Biol</source> <volume>17(11)</volume>: <fpage>3147</fpage>–<lpage>3153</lpage>.</mixed-citation>
</ref>
</ref-list></back>
</article>